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Abstract 
Aging in an osteoimmunological context; the contribution of the macrophage. 
Daniel Clark 
Aging is characterized by physiologic changes leading to a predisposition to a myriad of age-
related diseases. Accompanying these age-related diseases is a process of systemic 
inflammatory dysregulation known as inflamm-aging. This body of work focuses on fracture 
healing and periodontal disease, as both involve dysregulation of inflammation within bone and 
both demonstrate increased complications or prevalence with age. We chose to investigate the 
macrophage and its contribution to age-related pathologies affecting bone.  Macrophages are 
important regulators of inflammation during fracture healing and periodontal disease. An improved 
understanding of the age-related changes to macrophages will advance our understanding of the 
biology of aging and lead to enhanced healthcare for the aging population.   
Mouse models of fracture healing and periodontal disease using young and old mice were 
employed in this work.  Macrophages from young and old mice were characterized via RNA-seq. 
Macrophage were depleted pharmacologically during disease or fracture healing to elucidate the 
contribution of macrophages within the given models.  
The results demonstrated that macrophages from old mice present an aged-macrophage 
phenotype with increased pro-inflammatory and M1 gene expression. By eliminating the influence 
of the aged macrophage phenotype via macrophage depletion, periodontal disease severity was 
significantly reduced and fracture healing was significantly improved.  Further, we have 
demonstrated that TREM2 expression on macrophages is decreased with age which drove 
increased inflammatory cytokine expression and poorer fracture healing outcomes. Taken 
together, the aged-related changes that occur to the macrophage are likely involved in numerous 
disease pathologies, and this work presents potential therapeutic targets to address the 
macrophage-driven inflammatory dysregulation in the elderly population.   
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Chapter 1. The effects of aging on fracture repair 
1.1 Introduction 
The elderly population in the United States has been steadily increasing, and those aged 65 years 
old and older are expected to comprise 17% of the population by 2030 (1,2).  This growing 
population presents their own unique health needs, and in order to meet these needs a better 
understanding of the physiologic changes that occur with aging is necessary.  The skeletal system 
exhibits physiologic changes that occur with increasing age. Conditions such as osteoporosis and 
osteoarthritis increase with age.  Additionally, many reports demonstrate a higher rate of bone 
fracture, and these are associated with increased morbidity and mortality (3,4,5). A decline in 
healing potential is observed in the elderly, and this contributes to increased rates of delayed 
healing or non-unions (6). Delayed healing, and the resulting incapacitation, can have more 
severe and systemic consequences in the elderly, which poses unique challenges for the treating 
clinician (3,7).  While increased age has been generally associated with a wide range of 
physiological changes, the mechanisms that result in decreased capacity for fracture healing are 
not fully understood.  
An understanding of the age-related effects to fracture healing is complicated by a lack of a 
complete understanding of fracture healing in healthy and in young individuals.  However, by 
analyzing the individual facets of fracture healing that we do understand we can compare 
differences in fracture healing between the young and old humans and animals.  This review will 
highlight the phases of fracture healing and the respective physiologic changes that occur with 
age.  Cellular, molecular and genetic differences between young and old humans and animal 
models will be characterized to illustrate the current understanding of the effect of age on bone 
fracture healing.  Figure 1.1 summarizes the effect of age on critical cells that contribute to fracture 
healing.  
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1.2 Physiology of bone fracture healing 
Fracture healing proceeds through multiple phases characterized by anabolic and catabolic 
processes (8). The early healing stage is characterized by a robust inflammatory response that is 
responsible for debriding the fracture site and contributing to the signaling milieu that will 
propagate the successive stages of healing, including recruitment and differentiation of skeletal 
tissue progenitor cells (9).  The anabolic phase follows the initial inflammatory response. 
Progenitor cells give rise to a soft callus with a central cartilaginous region and new bone 
formation at the periphery (9,10).  The soft callus is characterized by avascular cartilage tissue 
that induces vascularization (11).  A hard callus begins to develop through endochondral 
ossification with increased mineralization and replacement of chondrocytes with osteoblast, in 
part, through transdifferentiation (12,13).  Finally, remodeling of the callus occurs through 
catabolic processes.  The callus is reduced in size and osteoblastic and osteoclastic processes 
alternate to reestablish the normal hematopoietic and trabecular structure, restoring bone to its 
pre-injured state (14).  
Histological and molecular changes within the callus have been described during the stages of 
fracture healing as mentioned above and provide healing comparisons between old and young 
animals. Numerous studies have reported delayed fracture healing in elderly animals and have 
shown decreased cartilage and bone formation, delayed cartilage resorption, and slower 
mineralization within the callus (15,16,17). Delayed bone healing may be associated with age-
related changes in the osteochondral stem cells.  In general, there is an age-related decrease of 
stem cell quantity compounded by a decrease in proliferation and differentiation potential as 
demonstrated in humans and animal models (18,19,20).  Lopas et al. demonstrated a decrease 
in osteochondral stem cell proliferation associated with a significant decrease in bone and 
cartilage content within the facture callus of aged mice compared to young (15).  
Chondrocytes and osteoblasts arise from stem cells predominantly located in the periosteum 
during fracture healing (9,21,22).  Senescence and greater oxidative damage was associated with 
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periosteal derived progenitor cells from old humans compared to young (23).  Additionally, a 
decreased number of periosteal cells were able to be derived from the periosteum of old humans 
compared to young (21).  The chondrogenic potential of stem cells in the periosteum is decreased 
in elderly mice compared to young mice, and chondrogenic differentiation from periosteal cells is 
delayed in old versus young mice (22,24). Older animals have delayed expression of Type 2 
collagen(ColII) and delayed cartilage matrix deposition at early time points of fracture healing (24). 
Similarly, osteoblast differentiation and osteocalcin expression is delayed from periosteal cells at 
the fracture site in elderly mice compared to young mice (24). 
Stem cells contributing to fracture healing may also arise from other tissue sources that could be 
negatively affected by age related changes. Cells located in muscle appear to contribute to bone 
fracture healing. While muscle stem cells, known as satellite cells, may contribute only a small 
number of cells that comprise the skeletal tissues, they appear to regulate fracture healing 
possibly through signaling interactions (25). With aging, satellite cell quantity and function decline 
which may negatively affect their ability to support fracture healing (26). However, the role of other 
cell types that reside in muscle is not known and worthy of investigation. The bone marrow is also 
a potential source of osteochondral stem cells (27,28).  Similar to satellite cells, aging results in 
decreased function and quantity of bone marrow stem cells that could have a negative effect on 
fracture healing (29,30).    
Age also affects later stages of healing during endochondral ossification.  The characteristic 
histological findings that describe endochondral ossification, hypertrophic chondrocytes, 
expression of type 10 collagen (ColX), and vascular invasion were all delayed in elderly mice 
compared to young mice (24).  Completion of endochondral ossification, characterized by 
complete conversion of cartilage to bone within the callus, was also delayed in elderly mice versus 
young mice (24).  
The age-related alterations to the cellular processes that are evident during facture healing are 
accompanied by changes in the regulation of critical genes involved in bone fracture healing.  By 
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using whole genome expression analysis of fracture calluses in rats, significant differential 
regulation of 144 genes were found in young compared to elderly rats (31).  Functional analysis 
of these genes suggested they were largely involved in cell migration (31).  More specifically, 
bone morphogenic protein (Bmp-2) and Indian Hedgehog (Ihh) expression in the fracture callus 
of elderly rats was decreased compared to young rats (32). Other studies have shown comparable 
levels of gene expression in the early time points of fracture healing; however, in elderly rats 
expression of Ihh, Bmp, and Tgf-β decreased at the same rate as the young rats despite requiring 
almost twice as long for complete healing to be detected radiographically (33). Thus, molecular 
changes occurring in cells comprising the fracture callus are evident in animals of advanced age, 
and these changes may contribute to the alterations in healing that are observed in older animals. 
However, systemic changes as a result of the normal process of aging also occur and could 
contribute to the delays in healing. 
1.3 Inflammation and fracture healing 
The initial phase of fracture healing is characterized by a robust inflammatory response.  
Secretion of pro-inflammatory cytokines at this time are necessary to initiate the healing process 
and achieve adequate healing (34). Temporal control of the inflammatory response is crucial for 
proper bone fracture healing. After the initial pro-inflammatory phase, inflammation must be 
resolved in order to allow the anabolic processes to begin and continue the subsequent healing 
phases. However, changes in the inflammatory system occur with age, and chronic inflammation 
and/or a decreased ability to resolve inflammatory processes could negatively affect bone fracture 
healing.  
1.4 Inflamm-aging and immunosenescence 
An excessive or prolonged inflammatory phase can have detrimental effects on fracture healing 
(35,36).  In animal models, prolonged inflammation results in delayed chondrogenesis and smaller 
callus size (37).  Recently, it was shown that elevated systemic levels of a pro-inflammatory 
cytokine, TNFα, in induced diabetic mice negatively affected angiogenesis during fracture healing 
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(38).  In humans, an elevated inflammatory status is related to certain systemic conditions, 
including diabetes, smoking, and increased age.  These conditions are all associated with poorer 
fracture healing outcomes, but the mechanisms remain incompletely understood.  The term 
“inflamm-aging” has been used to describe a chronic increased pro-inflammatory status in the 
elderly (39).  Elderly people are found to have higher levels of circulating pro-inflammatory 
cytokines, even in healthy individuals.  It appears the increased pro-inflammatory status in the 
elderly predisposes them to range of systemic diseases including osteoporosis, Alzheimer’s 
disease, Type II diabetes, atherosclerosis, and Parkinson’s disease (40,41,42). Currently, it is 
unclear what drives this increased inflammation.  Inflamm-aging has been suggested to be the 
result of a defect in the proper resolution of the normal inflammatory response, or the result of an 
unknown chronic mechanism that signals and prolongs the inflammatory response (43,44).  As 
the inflammatory response is a critical step in proper fracture healing, any disruption of the 
inflammatory response could negatively affect fracture healing. 
Inflamm-aging may also be a result of age-related changes to the immune response.   Aging of 
the adaptive immune response has been described as immunosenescence (45).  
Immunosenescence describes a loss of immune function that is associated with a predisposition 
to infection and disease in the elderly (45).  Increased age is associated with changes in T and B 
cell production and maturation.  T cell production and maturation is negatively affected by age 
related changes to the bone marrow hematopoietic compartment and to the thymus (46,47). With 
increasing age the source of T cell progenitors, the hematopoietic compartment, decreases in 
size and is associated with a decrease in T cell progenitor quantity and proliferation potential (47). 
The T cell progenitors migrate to the thymus for further differentiation and maturation.  A decrease 
in thymus function and T cell output is seen with increasing age as involution and atrophic 
changes are present (46). The lack of a sufficient quantity of T cells produced by the thymus 
negatively affects the ability to mount an effective immune response.  Additionally, the lack of T 
cells limits the availability of regulatory T cells that are present to resolve the mounted immune 
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and inflammatory response (46,48).  Immune cell trafficking has also been shown to be of 
importance in fracture healing studies showing impaired fracture healing in CCR2 deficient mice 
(49). CCR2 is a chemokine receptor for the ligands Ccl2, Ccl7, and Ccl12 that is expressed on 
monocytes, myeloid derived cells, a subset of T cells and mesenchymal stem cells. Recent 
studies in a muscle regeneration model have suggested that CCR2 deficiency in young mice 
results in an inflamm-aging environment similar to changes seen with aging (50). In this way, it 
has been proposed that the elevated pro-inflammatory status of inflamm-aging may be a response 
to age-related defects of the immune response. Figure 1.2 demonstrates a conceptual model of 
the effects of inflammatory response dysregulation on the subsequent stages of fracture healing. 
The age-related effects on inflammation during fracture healing can be investigated independently 
of other age-related changes to the organism by using a chimeric animal model.  Xing et al. used 
such a chimeric model of lethal irradiation followed by bone marrow transplant (51).  By irradiating 
aged mice and transplanting the bone marrow of young mice to those animals, investigators found 
that the osteochondral stem cells were derived from the aged host and the inflammatory cells 
were derived from the young donor in a fracture model.  In this manner, the older mice receiving 
young bone marrow had larger calluses and more bone in the early healing time points, more 
rapid callus remodeling at later stages of healing, and a rejuvenation of the inflammatory response 
compared to older mice receiving age-matched bone marrow transplants (51).  A similar study by 
Baht et al. utilized a parabiosis and a bone marrow transplant model of old and young mice in a 
fracture healing study (52). Fractures in old mice healed significantly better with shared circulation 
from a young mouse or with bone marrow transplants from young mice compared to aged-
matched old mouse donors.  No cells from the young donor circulation or bone marrow 
differentiated into skeletal cells in the callus suggesting a component of the circulation or bone 
marrow could revert osteochondral stem cells of old mice to a more youthful phenotype.  They 
further found that β-catenin was differentially expressed in old and young mice during fracture 
healing.  Shared circulation with young mice resulted in decreased levels of β-catenin and was 
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associated with improved fracture healing.  Decreasing β-catenin activity in old mice resulted in 
similar improvements in healing as sharing circulation with young mice.  The two studies 
described above suggest a crucial component regulating fracture healing of the hematopoietic 
environment that is affected by age-related changes.  
1.4 Cellular regulation of inflammation  
An understanding of the intrinsic age-related changes to cells involved in the inflammatory 
response may explain, in part, the poorer healing potential in the elderly. Cells of the innate and 
adaptive immune system local to the fracture site assist in regulating the inflammatory response.  
Macrophages are powerful regulators of inflammation. In the early inflammatory stage of healing, 
macrophages are classically activated and have an M1 phenotype (53,54).  M1 macrophages are 
pro-inflammatory and release cytokines IL-1, IL-6, TNF-α, iNOS to elicit and propagate the 
inflammatory response (53,54).  As inflammation is down-regulated in the later phases of fracture 
healing the macrophages acquire an alternatively activated M2 state.  M2 macrophages express 
anti-inflammatory cytokines, such as IL-10 and promote healing through secretion of growth 
factors TGFβ, VEGF, and PDGF (53,55).  Temporal control of the polarization of M1 and M2 
macrophages is important to regulate inflammation during the healing process.   
Intrinsic age-related changes to macrophages may perturb the inflammatory response in the 
elderly and may have negative consequences for fracture healing.  Aged macrophages were 
found to be less responsive to granulocyte macrophage colony-stimulating factor (GM-CSF) that 
resulted in decreased proliferation compared to young macrophages (56).  Additionally, elevated 
serum levels of chitotriosidase, a marker for chronically activated macrophages, was found in 
elderly humans compared to young controls (57). The negative effects of age-related changes to 
macrophages are further supported in animal models of healing. Cutaneous wounds heal slower 
in aged mice and can be rescued with transplants of macrophages from young mice (58). Further, 
aged macrophages appear to be detrimental to healing.  In blocking macrophage recruitment to 
the fracture site, elderly mice appear to exhibit better fracture healing compared to elderly mice 
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that had normal macrophage activity (59).  Conversely, in the same experiment, blocking 
macrophage recruitment to the fracture site in young mice had a negative effect on fracture 
healing (59).   
Macrophages are known to contribute to bone healing. A tissue resident population of 
macrophages, termed “osteomacs,” has recently been described (60).  Osteomacs regulate 
osteoblast function and promote fracture healing; blocking their activity has deleterious effects on 
bone healing (60,61). While it appears clear that circulating macrophages that are recruited to the 
site of bone injury have age-related changes that hinder fracture healing, whether age-related 
changes occur in osteomacs is not known.  
Cells of the adaptive immune system also contribute to fracture healing (62). T and B cells are 
present within the early callus during the inflammatory phase (63). Regulatory B cells negatively 
regulating inflammation through expression of IL-10 and downregulating pro-inflammatory 
cytokine expression in T cells within the callus (64). B cells from patients with poor fracture healing 
outcomes had decreased expression of IL-10 compared to patients that healed normally (64).  As 
healing continues, cartilage formation within the callus is associated with a local increase in Treg 
cells (65). At later time points of healing, T and B cells are readily present at sites of mineralization 
and in direct contact with osteoblasts and osteoclasts (63).  Models of fracture healing using mice 
with genetic modifications have further elucidated the role of T and B cells.  Deficient T and B cell 
function in Rag1-/- mice demonstrated impaired fracture healing which was associated with 
decreased IL-17F expression (66).  IL-17F was shown to promote osteoblast maturation in vivo 
(66).  Additionally, dysregulated T cell recruitment and activation within the bone in a mouse model 
of lupus was associated with increased bone turnover and decreased bone fraction within the 
fracture callus (65).  As discussed above, T and B cell quantity and function are negatively 
affected by age.  Due to the involvement of T and B cells in fracture healing, such age-related 
changes could have a negative effect on fracture healing. 
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Mesenchymal stem cells are also involved in the inflammatory response and act as powerful 
immunomodulators at the site of injury to control excessive inflammation and promote repair 
(67,68,69). Suppression of inflammation mediated by MSCs occurs, in part, through signaling and 
interactions with local inflammatory cells.  MSCs have been shown to interact with T-cells, B-cells, 
NK cells, and dendritic cells through signaling that limits proliferation of inflammatory cells or 
promotes secretion of anti-inflammatory molecules (70).  Additionally, research has suggested 
MSC and macrophages interact to promote alternatively activated macrophages in the 
downregulation of inflammation and promotion of healing (71).  The immunomodulatory properties 
of MSCs have been utilized clinically and have been reported beneficial in the treatment of graft 
versus host disease, Crohn’s disease, renal failure, and heart failure (72-75). 
Intrinsic age-related changes to MSCs could explain the impaired healing in older humans and 
animals as a result of dysregulated inflammatory response. The quantity of MSCs isolated from 
bone marrow is decreased with age (30).  Additionally, there are increased markers for oxidative 
damage of MSCs from elderly human samples (58). These age-related changes to MSCs 
corroborate findings in experimental wound healing studies that show a benefit of therapeutic 
administration of MSCs from young animals but no benefit in healing with aged MSCs (58). 
1.5 Vasculature and fracture healing 
Successful bone fracture healing requires adequate vascularization of the tissue (76).  The 
contribution of the vasculature to fracture healing includes providing a blood supply for delivery of 
nutrients and cells, providing the endothelial cells that express angiogenic and osteogenic 
signaling molecules locally, and providing the source of oxygen to the healing callus (9,77,78).  
However, the complete contribution of the vasculature to fracture healing is not fully understood.   
With increasing age, perturbations in bone fracture healing are associated with age-related 
dysfunction to the bone vascular system and its ability to regenerate in healing. Generally, the 
vascular perfusion of the skeleton decreases with age (79).   Elderly rats display significantly 
higher ossifications and decreased patency of bone marrow blood vessels compared to younger 
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rats (80).  The decrease in vascularization at the time of fracture may delay angiogenesis during 
the fracture healing.  The fracture callus at early healing time points in young mice have a higher 
surface density of blood vessels compared to the elderly mice (77).  The increase in vascular 
density was associated with an early detection of vascular endothelial growth factor (VEGF) and 
Hypoxia inducible factor 1α (HIF-1α) in young mice but not elderly (77).  Additionally, increased 
Mmp9 and Mmp13 transcripts were detected throughout early and late stage healing in young 
compared to old mice (77).  Differential expression of angiogenic factors, including VEGF, HIF-
1α, and Mmps, have been well demonstrated in young animals versus old during bone fracture 
healing (81,82,83). 
1.6 Conclusions 
Increasing age has been shown to negatively affect the cellular and molecular processes 
throughout the different stages of bone fracture healing.  Inflammatory regulation, cellular 
differentiation and signaling cascades are all affected, in part, by age-related changes.  Our 
current understanding of these age-related changes explains, only partially, the decreased 
healing potential and increased complications observed during fracture healing in elderly patients.  
A more complete understanding is necessary to allow for therapeutics to target the specific age-
related deficiencies and provide better care for the increasing geriatric population.     
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Figures: Chapter 1 
Figure 1.1 The effect of age on the cellular contribution to fracture healing. Stem cells and 
immune cells involved in fracture healing demonstrate age-related changes that may negatively 
affect fracture healing. Osteochondral stem cells arise from the periosteum and bone marrow and 
demonstrate decreased quantity, increased oxidative damage, and decreased osteoblastic and 
chondrogenic differentiation potential with age.  T-cells contribute to fracture healing and 
production and maturation of T-cells is negatively affected by age related changes to the bone 
marrow hematopoietic compartment and to the thymus. Macrophages are important regulators of 
inflammation during fracture healing.  Aged macrophages demonstrate decreased proliferation 
and increased activation that may contribute to the poorer healing outcomes associated with aged 
macrophages compared to young.  Finally, adequate vascularization is required for successful 
fracture healing. Aged animals demonstrate decreased vascular density within the callus which 
is associated with decreased levels of key angiogenic factors required for healing.  
12 
 
 
Figure 1.2. The effects of inflammatory response perturbation on the stages of fracture healing. 
(A) Fracture healing follows three general stages of inflammation, proliferation and remodeling.  
The initial inflammatory response is tightly regulated and crucial in initiating the subsequent 
stages of healing. (B) Systemic conditions, including increased age, have an effect on 
inflammation and may result in differential inflammatory responses during fracture healing.  
Senescence of the inflammatory response results in a decreased and limited inflammatory 
response (blue curve) that may result in inadequate activation of the proceeding healing stages.  
An exaggerated and sustained response (orange and red curves) can result from inadequate 
resolution of the response and may negatively affect the proceeding stages. An increased basal 
level of inflammation (red curve) is proposed to occur with inflamm-aging and would have possible 
negative effects throughout the healing process.  
13 
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Chapter 2: The effects of aging on periodontal disease 
2.1 Introduction 
Periodontal disease affects 48% of adults in the United States (1). Disease is initiated by a host 
inflammatory response to the local presence of bacterial plaque (2).  Inadequate clearance or 
sustained presence of the bacterial plaque will prolong the host inflammatory response and 
eventually lead to tissue damage to the host (2).  The sustained host response can eventually 
lead to the induction of periodontal disease with the associated loss of tooth-supporting soft and 
hard tissue. Through the progression from health to periodontal disease, complex changes occur 
to the microbial composition as well as the cellular and molecular immune response that all 
contribute to the pathogenesis of periodontal disease (3).   
The prevalence and severity of periodontal disease increases with age, affecting over 60% of 
those over the age of 65 (1,4). As periodontal disease progresses, the loss of tooth support results 
in difficulty eating, speaking, unacceptable esthetics, and ultimately to the loss of teeth (5).  
Periodontal disease in elderly individuals can be detrimental to their systemic health.  A lack of 
proper function when eating can restrict their diet and result in malnourishment (6).  Similarly, the 
systemic inflammatory burden as a result of periodontal disease can contribute to or worsen the 
myriad of diseases and conditions that have higher prevalence with age, including diabetes, 
kidney disease, Alzheimer disease, and cardiovascular disease (7).  Therefore, it is important to 
understand why the prevalence of periodontal disease increases with age to allow for more 
directed treatment in a susceptible population.   
2.2 Periodontal disease pathogenesis 
During periodontal disease, tissue destruction is ultimately caused by the host inflammatory 
response. Therefore, it is important to understand how the inflammatory response changes as a 
function of age.  Periodontal disease is one of many diseases that become more prevalent with 
increased age.  As described in the previous section, diseases such as Alzheimer’s disease, Type 
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II diabetes, atherosclerosis, and Parkinson’s disease all become more prevalent with increased 
age and all share an underlying dysregulated inflammatory component that predisposes or 
contributes to such diseases.  The term inflamm-aging has been used to describe the 
dysregulated pro-inflammatory status in the elderly (8).  It is unknown if inflamm-aging results 
from a chronic signal that maintains the inflammatory response or from a defect in the resolution 
of inflammation (9).  As periodontal disease arises from a dysregulated host response, it can be 
appreciated how the dysregulation that occurs with inflamm-aging would impact the pathogenesis 
of periodontal disease in elderly individuals. Disruption of systemic inflammation has been shown 
to be associated with periodontal disease. Systemic disease such as type II diabetes and obesity 
are characterized by elevated systemic inflammation and both diseases demonstrate increased 
prevalence of periodontal disease. In obese patients, higher levels of circulating TNFα was 
associated with the higher prevalence of periodontal disease in those patients (10). In diabetic 
patients, higher blood glucose levels were associated with increased alveolar bone loss (11).  It 
also should be noted that there is a likely a bidirectional relationship, where there is an increased 
systemic inflammatory burden as a result of periodontal disease that can predispose or worsen 
type II diabetes and obesity in an individual (12). The association of periodontal disease with 
obesity and type II diabetes again points to a shared underlying inflammatory component.  
The cause of inflamm-aging remains unknown and is likely multifactorial. Investigating age-related 
changes in immune cells may lead to a better understanding of the biology of aging and could 
lead to therapeutic targets to mitigate the effects of inflamm-aging in periodontal disease. Cells of 
the innate and adaptive immune response are involved in the pathogenesis of periodontal 
disease.  Macrophages and T cells are both important regulators of inflammation and have 
demonstrated age-related changes. Their role in periodontal disease and possible contribution to 
inflamm-aging is expanded upon below. 
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2.3 Macrophages and the innate immune response 
Age-related changes to cells of the innate immune response have largely been implicated in 
inflamm-aging. The innate immune system is responsible for the initial host response to bacterial 
plaque (13). Neutrophils, macrophages, natural killer cells, and dendritic cells are involved in the 
innate response, with each cell type presenting different aging phenotypes (8,30).  The 
macrophage is a key modulator of the innate immune system and can display both a pro-
inflammatory (M1) and anti-inflammatory (M2) phenotype to regulate the disease process (14,15). 
The M1 phenotype is involved with bacterial killing and, thus, is present in response to bacterial 
plaque during periodontal disease (13). After adequate removal of the bacterial plaque, a timely 
phenotypic switch away from M1 is required to prevent tissue damage as a result of the pro-
inflammatory phenotype, and the M2 phenotype is then present to aid in the resolution of 
inflammation and promote healing of damaged tissues. The presence of M1 and M2 type 
macrophages has been shown to be related to increased and decreased severity of periodontal 
disease respectively (16,17). The higher prevalence of M1 macrophages was associated with 
increased inflammatory cytokines within the gingiva of humans with periodontal disease 
compared to healthy controls (18). 
The plasticity of the macrophage makes it an interesting cell to study, as control over the differing 
phenotypes is an attractive therapeutic target. Systemic inflammatory diseases, such as 
metabolic syndrome, cardiovascular disease, and rheumatoid arthritis, have shown the 
involvement of macrophages in their pathogenesis, and treatment directed towards macrophages 
in these conditions has shown promise (19,20,21,22). Additionally, chronic inflammatory 
conditions affecting the bone, such as arthritis, have shown improvements in animal models by 
depleting the macrophages (23), further suggesting that macrophages are a viable therapeutic 
target in osteolytic diseases like periodontitis  
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As described in the previous chapter, macrophages have demonstrated age-related changes that 
affect cytokine and growth factor production as well as being implicated in poor wound healing 
outcomes. The systemic disease mentioned above (metabolic syndrome, cardiovascular disease, 
rheumatoid arthritis) that have benefited from macrophage-targeting therapies are also disease 
that are more prevalent with increased age. This observation further suggests that age-related 
changes to macrophages may contribute to inflamm-aging and the associated age-related 
diseases such as periodontal disease.  
In general, the age-related changes to macrophages would be predicted to contribute to the 
pathogenesis of periodontal disease by promoting a local increased pro-inflammatory status. 
Circulating macrophages from elderly individuals demonstrated an increased pro-inflammatory 
status (24,25).  Defects in phagocytosis in old macrophages have also been demonstrated 
(26,27). Inefficient clearance of microbes or necrotic and apoptotic debris within the periodontium 
would result in the maintenance of a pro-inflammatory state.  However, age-related changes 
demonstrated in circulating macrophages or using in vitro models are not necessarily replicated 
within the periodontium (28,29).  To date, a full understanding of the age-related changes to 
macrophages and its affect on periodontal disease is lacking.  However, our understanding of 
macrophage activity in other diseases suggests that age-related changes to macrophages are a 
likely contributing factor to the pathogenesis of periodontal disease and could serve as a 
therapeutic target in the management of disease in both young and elderly patients. 
2.4 T Cells and the adaptive immune response  
While age-related changes to the innate immune system has been linked to inflamm-aging, age-
related changes to the adaptive immune response have generally been associated with 
immunodeficiency.  Activation of the adaptive immune response is characterized by the activity 
of T cells and B cells in the production of antibodies and cellular immunity (31).  Age-related 
changes to T and B cells affect their activation and proliferation centrally as well as their 
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recruitment and function local to the site of inflammation (32). The immunodeficiency observed in 
elderly individual has been associated with immune senescence, specifically a decrease in T cell 
and B cell function. With increased age there is an involution of the thymus, the site of naïve T 
cell production, resulting in an overall decline in naïve T cell numbers (33).  Similarly, decreased 
generation of progenitor B cells from the bone marrow is observed with increased age (32).  
Overall, these age-related declines in naïve B and T cell quantity results in a decline of antigen-
specific immunity and the resulting immunodeficiency with increased susceptibility to infection in 
the elderly (31). The immunodeficient status associated with increased age would be expected to 
result in a susceptibility to subgingival microbial infection during periodontal disease.  However, it 
is unclear if the increased prevalence of periodontal disease is a result of the immune senescence 
or from the inflamm-aging phenotype described earlier. 
As T cells interact with antigen presenting cells, they further differentiate into sub-populations with 
distinct functions.  CD4+ T helper cells are generally characterized as Th1 and Th2 based upon 
their cytokine secretory profile and resulting ability to activate pro-inflammatory cells (Th1) or 
involvement in the resolution of inflammation (Th2) (34).  One subset of Th1 cells that has been 
implicated in periodontal disease is Th17 cells, named after their characteristic production of IL-
17 (35). Th17 cell expansion and IL-17 expression are pathogenic mediators in periodontal 
disease (36,37). There are multiple cellular sources of IL-17 within the gingiva; however, during 
periodontal disease Th17 cells represent 80% of the IL-17+ cells (36). Inhibition of Th17 cell 
differentiation was shown to decrease disease severity (36).  Interestingly, Th17 cells 
demonstrate increased homeostatic expansion with increased age (38); however, it is unknown 
what drives this age-related expansion. Homeostatic Th17 cell expansion requires IL-6 (38), 
pathogenic expansion of Th17 cells requires IL-6 and IL-23 signaling (35).  IL-6 expression from 
the epithelium has been reported to promote homeostatic expansion of Th17 cells (38); however, 
other drivers of homeostatic and pathogenic Th17 expansion are unknown. Given the pro-
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inflammatory nature of IL-6 and IL-23, cells of the innate immune response known to express 
those cytokines could be involved in Th17 expansion.  The effect of inflamm-aging on those innate 
cells could result in further production of the cytokines and increased Th17 expansion with age.   
2.5 Conclusion 
The inflamm-aging phenomenon contributes to the myriad of age-related disease and more recent 
work has similarly shown inflamm-aging to have a detrimental effect on periodontal disease.  
While this review focused on the immune system, a host of other age-related changes may also 
contribute to the increased prevalence of periodontal disease in the elderly.  Known age-related 
changes to the microbiota may have a detrimental effect on periodontal disease (39). Additionally, 
age-related changes to the periodontal tissue structure and integrity may result in a susceptibility 
to disease (40). Finally, decreased progenitor capacity of mesenchymal stem cells in older 
humans may result in perturbed tissue repair after an inflammatory insult during periodontal 
disease (41,42).  These topics, and more, may further contribute to the increased prevalence of 
periodontal disease in elderly populations and warrant further investigation and discussion.   
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Chapter 3: Age-related changes to macrophages and the impact on fracture healing. 
3.1 Introduction 
Perturbation of the inflammatory phase of fracture repair can have detrimental effects on the 
healing outcome (1,4).  This is evident in patients with chronic inflammatory conditions such as 
diabetes, rheumatoid arthritis, and increased age (2).  The disturbance of inflammation in these 
conditions is associated with poorer fracture healing outcomes (5-8). Similarly, in experimental 
animal models, induced local and systemic inflammation has negative effects on fracture healing 
outcomes (9-11).   
As described in Chapter 1, the elderly population, including those in good health, are found to 
have higher levels of circulating pro-inflammatory cytokines, which is associated with a 
predisposition to a range of systemic disease including osteoporosis, Alzheimer’s disease, Type 
II diabetes, atherosclerosis, and Parkinson’s disease (19-21). The chronic, increased pro-
inflammatory status associated with aging is described as “inflamm-aging” (22,23).   Currently, 
the mechanisms responsible for inflamm-aging are unclear. Therefore, understanding how 
dysregulation of the inflammatory process in elderly populations affects fracture healing 
represents a critical area for investigation.   
To this effort our group has been investigating age-related changes to the macrophage as a 
possible contributor to the inflammatory dysregulation observed in elderly populations. The 
macrophage is an important inflammatory cell involved in fracture healing (25,26). Throughout the 
course of healing, macrophages polarize among various states of inflammation in response to 
their environment. During early phases of healing macrophages are classically activated and 
exhibit pro-inflammatory activities. These have been generally considered M1 macrophages 
(27,28). As healing progresses macrophages switch to anti-inflammatory states and are generally 
considered M2 macrophages that are responsible for downregulating inflammation and promoting 
healing (28,29). However, these are very broad categories and not strict definitions of cell types, 
and in actuality these categories are likely comprised of multiple subsets of macrophages 
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comprising these populations. Nonetheless, enhancement of M2-like macrophages at the fracture 
site has been shown to improve fracture repair (30). In addition, tissue-resident macrophages, 
osteomacs, have been observed in close proximity to osteoblasts on the bone surface, and 
contribute to osteoblast regulatory functions (31). Macrophages promote osteoblast differentiation 
during fracture healing (32), and we have also shown the importance of macrophages in fracture 
healing.  Fracture healing in mice that lack C-C Motif Chemokine Receptor 2 (Ccr2) exhibits 
disruption of macrophage trafficking to the fracture callus and delayed fracture healing (33), and 
others have observed similar results after depletion of macrophages in mouse models (25,30,32). 
Finally, age-related changes to macrophage activity have been previously demonstrated. 
Dysregulated chemokine and cytokine expression has been observed in aged macrophages 
compared to young (34). Additionally, decreased growth factor production is associated with aged 
macrophages (35). Hence, these changes could significantly impact fracture healing in aged 
animals.  
In this work, our goal was to better understand the contribution of the inflammatory response in 
aged animals, and specifically the macrophage, during fracture healing. We assessed influx of 
inflammatory cells to the fracture site in young and elderly mice and used next-generation RNA 
sequencing to assess age-related changes in the transcriptome of macrophages derived from the 
fracture callus. Finally, we manipulated macrophages in elderly mice to asses the extent to which 
they can be targeted for therapy. Our results add to the increasing body of evidence supporting a 
role for the inflammatory system in bone fracture healing.  
3.2. Materials and methods 
3.2.1. Animals 
All procedures were approved by the UCSF Institutional Animal Care and Use Committee and 
conducted in accordance with the National Institutes of Health guidelines for humane animal care. 
All mice (C57B6/J) were obtained from the National Institute on Aging’s Aged Rodent Colony. 
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Specific pathogen-free mice were bred and raised in barriers and utilized for experiments at 24 
months (old adult mice) or 3 months (young adult mice) of age.  
3.2.2. Tibia fractures 
Mice were anesthetized and subjected to closed, non-stable fractures of the right tibia created by 
three-point bending, as previously described (36). Analgesics were administered post-surgery 
and mice were permitted to ambulate freely. To inhibit macrophage recruitment during fracture 
healing in old mice, treatment groups received the compound PLX3397 (275mg/kg) (Plexxikon 
Inc. Berkeley, CA) ad libitum in their chow. Control groups received the same chow without 
PLX3397. PLX3397 is a small molecule kinase inhibitor of Colony stimulating factor 1 receptor 
(M-CSF1R) (37). The compound significantly reduces the quantity of macrophages in the fracture 
callus (38). Treatment with PLX3397 was started 24 hours before fracture and continued for 3 or 
10 days after fracture until the animal was euthanized and the tissues harvested for analysis.  
3.2.3. Tibia processing and stereology 
Mice were sacrificed at day 10-post fracture for stereological analysis of the fracture callus.  
Fractured tibiae were collected and fixed for 24 hours in 4% paraformaldehyde.  The tibiae were 
decalcified in 19% EDTA for 14 days and dehydrated in graded ethanol prior to paraffin 
embedding. Serial sagittal sections (10μm) were cut through the entire tibia using a microtome 
(Lecia, Bannockburn, IL) and mounted on slides.  Sections were stained using Hall Brunt 
Quadruple Stain (HBQ) to visualize bone and cartilage. An Olympus CAST system (Center Valley, 
PA) and software by Visiopharm (Hørsholm, Denmark) was used to quantify tissue volumes 
according to stereological methods developed by Howard and Reed (39). A 2x magnification 
setting was utilized to outline the boundary of the fracture callus. Then, bone and cartilage were 
identified and labeled at 20x magnification. The Cavalieri formula was used to estimate the 
absolute volume of the total callus, bone, and cartilage tissue as previously described (17,24,33).   
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3.2.4. Flow cytometry 
Old and young mice were sacrificed at days 1, 3, 10, and 14 post fracture.  Fractured tibiae were 
collected and the calluses were dissected, weighed, disassociated manually through a 100µm 
nylon cell strainer, and digested with Collagenase type I (0.2mg/mL; Worthington, Lakewood, NJ) 
for 1 hour at 37 degrees.  Cells were rinsed, collected by centrifugation, and resuspended in 
incubation buffer (0.5% BSA in PBS).  Isolated cells were blocked for 10 minutes at room 
temperature in 10% rat serum and then stained with directly conjugated fluorescent antibodies: 
CD45 (clone 30-F11), CD3 (145-2C11), B220 (RA3682), Gr-1 (RB6-8C5),  NK1.1 (PK136), MHC 
Class II (M5/114.15.2) Ly6 C (HK1.4) Ly6G (clone 1A8), F4/80 (clone BM8), and CD11b (clone 
M1/70) (Biolegend, San Diego, CA). Staining with Fixable Red Dead (Thermo Fisher, Waltham, 
MA) was used for the detection of dead cells. Isotype controls and fluorescence minus one 
controls were used to gate for background staining. Cells were sorted on a FACSAria (BD 
Biosciences, San Jose, CA), and FlowJo Software 9.6 (Treestar, Ashland, OR) was used for 
analysis.  
3.2.5. RNA-seq Analysis 
Macrophages were isolated from the fracture callus of old (n=10), old treated with PLX3397 (n=6) 
and young (n=11) mice at day 3 post-fracture. The callus was dissected and cells were collected 
as described above.  For the detection and isolation of macrophages, cells that stained with the 
following directly conjugated florescent antibodies CD3 (145-2C11), B220 (RA3682), NK1.1 
(PK136), Ly6G (clone 1A8) were excluded, and macrophages were collected by staining with 
CD45 (clone 30-F11), F4/80 (clone BM8), and CD11b (clone M1/70) (Biolegend, San Diego, CA). 
Callus macrophages were sorted to 99.8% purity on FACSAria (BD Biosciences, San Jose, CA).  
RNA was extracted using Invitrogen RNA aqueous Micro Kit (AM1931). The library was prepared 
using Illumina Truseq Stranded mRNA Library Prep Kit and Single-end 50 bp RNAseq was 
performed on Illumina HiSeq 4000. An average read depth of 60.7 million reads per sample was 
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generated. Reads were aligned using STAR_2.4.2a to the mouse genome (Ensemble Mouse 
GRCm38.78). Differential gene expression was assessed using DEseq2. Gene ontology and 
KEGG pathway analysis was performed using DAVID (http://david.abcc.ncifcrf.gov) and the 
mouse genome was used as background.  
3.2.6. Statistics 
GraphPad Prism v.7 software was used for analysis. Comparisons between groups was made by 
first using a 2-way ANOVA multiple comparisons test followed by a 2-tailed Student’s t test. 
P<0.05 was considered statistically significant. Differential gene expression was considered 
significant at FDR<0.1. For term enrichment in gene ontology and KEGG pathway analysis the 
level of significance was set using a modified Fisher Exact P-value of p<0.05. 
3.3 Results 
3.3.1. Old mice demonstrate delayed fracture healing compared to young mice 
Previously, we have shown that the rate of fracture healing is directly related to the age of mice. 
Eighteen month-old mice healed slower than 1 and 6 month old mice (17).  Therefore, to begin 
this work we compared fracture healing in 24 month-old mice, because these are considered 
elderly (40), to young adult mice (3 months old). Fracture healing was assessed using stereology 
to quantify the volume of bone and cartilage within the fracture callus.  At 10 days post-fracture, 
old mice had smaller calluses with significantly less bone and more cartilage (p<0.05) compared 
to young adult mice (Fig. 3.1).  Thus, these data are in agreement with our earlier work.  
3.3.2. Immune cell infiltration into the fracture callus is similar in old and young mice 
Our objective was to examine the effect of age on inflammation during fracture healing. First, we 
assessed the inflammatory response during fracture healing in old and young mice by quantifying 
lymphocyte infiltration into the fracture callus at 1, 3, 10, and 14 days post fracture via flow 
cytometry. The quantity of T cells, natural killer T cells, and natural killer cells isolated from the 
callus was similar in young and old mice at all time points examined (n=5 mice/ group) (Fig. 3.2A).  
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In contrast, B cells were significantly increased in young mice at day 10 (p<0.05). Macrophages 
were the most prevalent immune cell analyzed among cells derived from the fracture callus. The 
quantity of macrophages peaked 3 days after fracture, and the macrophages were reduced 
dramatically by day 14, but, no significant differences were noted in the quantity of F4/80+ 
macrophages in old and young fracture calluses at any time point analyzed (Fig. 3.2B). However, 
in examining subpopulations of macrophages, the F4/80+, Ly6C- population, indicative of a 
“restorative” macrophage phenotype (41) was increased within the fracture callus of young mice 
compared to old mice at day 1, but this difference had resolved by day 3 (Fig. 3.2C). Our data 
suggest that there may be slight differences in the cellular inflammatory response in young and 
old mice, but the differences are subtle.  
3.3.3 Callus macrophages from old mice are transcriptionally distinct from callus macrophages 
from young mice. 
Since the quantity of immune cells infiltrating the fracture callus was similar in young and old mice, 
functional, rather than quantitative, changes in these cells may contribute to inflammatory 
dysregulation upon aging. The macrophage was selected for further analysis, because 
macrophages were the most abundant immune cell type analyzed, and we observed differences 
in a subpopulation of macrophages, F4/80+,LyC-, between young and old mice. To evaluate 
intrinsic age-related changes in macrophages, RNA-seq analysis was performed on 
macrophages isolated from the fracture callus of old and young mice at 3 days post fracture. In 
total, 1222 genes were significantly differentially expressed in old macrophages compared to 
young; 364 genes were upregulated and 200 genes were down-regulated more than 2-fold (Fig. 
3.3A). Gene ontology enrichment analysis was performed to begin exploring the implications of 
these differentially expressed genes in macrophages (Fig. 3.3B). A number of significantly 
enriched disease processes are identified that are related to aging and the immune response. 
These enriched terms include rheumatoid arthritis, graft versus host disease, inflammatory bowel 
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disease.  Additionally, molecular and cellular processes important in macrophage function were 
significantly enriched, including antigen processing and presentation, response to wounding, and 
cytokine activity. These suggest that fundamental differences in function of young and old 
macrophages may contribute to age-related differences in inflammatory response to fracture.   
The 1222 significantly differentially expressed genes in the macrophages from old and young 
fracture calluses is compared with a heat map (Fig. 3.3C).  Hierarchical clustering based on 
Euclidean distances demonstrates old and young animals sort largely based upon differential 
gene expression patterns (Fig. 3.3C). The heatmap further characterizes old mice as more 
heterogeneous in their transcriptomes than young animals. To further assess differences between 
old and young macrophages, samples were hierarchically sorted based on their differential 
expression of 14 genes associated with characteristic macrophage cytokines and markers of M1 
and M2 macrophages. This analysis demonstrated that mice sort by age and that old mice have 
increased expression of pro-inflammatory cytokines and markers of M1 macrophages (Fig. 3.3D). 
Principal component analysis further demonstrates distinct clustering of the young mice from old 
(Fig. 3.3E).  The heterogeneity of the old macrophage transcriptome is further seen in the principal 
component analysis with young mice demonstrating closer clustering compared to old mice that 
span PC1 and PC2 (Fig. 3.3E). Median PC scores of old and young mice across the individual 
principal components additionally demonstrate the difference by age and the increased variability 
in the old mice (Supplementary Fig. 3.1).  PC1 appears to largely separate the old from young 
mice.  Although, three old mice are seen clustering with the young mice in all analyses performed, 
further supporting the idea that cells from old mice are more variable in their gene expression 
profiles than young mice.  Genes with the highest and lowest eigenvalues on PC1 are presented 
in Supplementary Table 3.1. 
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3.3.4. Inhibition of macrophage recruitment improves fracture healing in old mice 
Macrophages from the fracture calluses of old mice were transcriptionally distinct and displayed 
a more pro-inflammatory phenotype compared to young macrophages. Thus, we sought to inhibit 
macrophage recruitment during fracture healing to assess if healing outcomes could be improved 
in old mice. We administered a CSF-1R inhibitor, PLX3397, that inhibits recruitment of 
macrophages from the bone marrow. Administering PLX3397 for 10 days after fracture healing 
improved fracture healing outcomes (Fig. 3.4). Stereological analysis demonstrated a larger 
fracture callus with significantly increased bone volume in treated old mice compared to control 
old mice (Fig. 3.4B). Flow cytometry demonstrated significant reduction of macrophages within 
the callus of PLX3397 treated mice (Fig. 3.5A).     
3.3.5. Improved fracture healing is associated with transcriptionally “younger” macrophages 
To understand how the transcriptional profile of callus macrophages changes with PLX3397 
treatment, we collected macrophages from the fracture callus of mice treated with PLX3397 at 3 
days post-fracture.  RNA-seq analysis demonstrated that only 64 genes were significantly 
differentially expressed in old macrophages from mice treated with PLX3397 compared to young 
macrophages; 27 genes were up-regulated and 28 genes were down-regulated more than 2-fold 
(Fig. 3.5B).  Hierarchical clustering by Euclidean distance demonstrates that macrophages from 
old mice treated with PLX3397 cluster between macrophages from young and old mice without 
treatment (Fig. 3.5C).  Principal component analysis further demonstrates that the macrophages 
from old mice treated with PLX3397 cluster closely with the young mice compared to the old with 
less transcriptomic heterogeneity (Fig. 3.5D).  This suggests that the inflammatory macrophages 
that are recruited to the bone fracture are substantially different between old and young mice, but 
the remaining tissue resident macrophages demonstrate less age-related changes. 
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3.4 Discussion 
The results from this study demonstrate that an aged macrophage phenotype is detrimental to 
fracture healing. Using an unbiased next generation sequencing approach, we demonstrate 
differences in the gene expression signatures of macrophages that infiltrated the fracture site in 
young and old mice. Macrophages from old mice have a more M1, pro-inflammatory gene 
signature than macrophages from young animals.  Further, we demonstrated that a 
pharmacologic (PLX3397) leading to a decrease in macrophages recruitment to the fracture site 
of old mice improves fracture healing outcomes. In older mice treated with PLX3397, 
macrophages that are present within the callus appear transcriptionally “younger”, suggesting that 
the detrimental age-related changes may occur in infiltrating macrophages. 
The delayed fracture healing we observed in the elderly mice compared to young adults here (Fig. 
3.1) is similar to our previous findings (17). Other groups have shown delayed healing with 
decreased callus size and decreased bone volume at multiple time points post fracture in old mice 
compared to young (18,42). Substantial alterations in inflammation may affect fracture healing in 
aged animals. For example, inflammation induced with Lipopolysaccharide led to decreased 
callus strength in young animals (10), and delayed healing in aged animals has been directly 
associated with inflammatory dysregulation within the callus in aged mouse models of fracture 
healing (24,43). Other studies have demonstrated an association of systemic inflammatory 
dysregulation, as a result of increased age or disease, with poor fracture healing outcomes in 
humans and animal experiments (4-6,44). In fact, we have shown that transplantation of juvenile 
bone marrow into lethally irradiated middle-aged animals stimulates bone fracture healing, and 
this is associated with decreased inflammation (24). This work was subsequently confirmed (45). 
However, the inflammatory cells responsible for the stimulatory effect remain largely unknown.   
Recent work has suggested that macrophages may underlie the dysregulation of inflammation 
seen during fracture healing in aged animals. Our preliminary research demonstrated that 
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reducing the influx of inflammatory macrophages into the callus of aged animals stimulated 
healing (38). Other work has advanced this observation and supports the idea that aging 
macrophages are deleterious to healing (45,24). Interestingly, depletion of macrophages in 
healthy young mice has also been shown to be deleterious to fracture healing (30,32,33). 
Collectively, this work supports the important role for macrophages in fracture healing and the 
deleterious effect of age-related changes to macrophages on fracture healing outcomes. 
The age-related changes in fracture healing does not appear to be a function of significant 
differential inflammatory cell recruitment. We observed similar numbers of immune cells infiltrating 
the fracture callus in young and old mice (Fig. 3.2). T cells may contribute to fracture healing 
largely through the recruitment and activation of osteoclasts (46). The aging immune system is 
characterized by decreased naive T cell quantity and weaker activation in elderly populations 
compared to young (47). However, the quantity of T cells within the fracture callus did not differ 
by age (Fig. 3.2A). Similarly, the quantity of F4/80+ macrophages did not differ by age; however, 
a sub-population of macrophages, identified as F480+ Ly6C-, was increased at day 1 post fracture 
in young animals but this difference was not apparent by day 3 (Fig. 3.2C).  Macrophages that 
are F4/80 positive and Ly6C negative have been suggested to be anti-inflammatory or M2-like 
macrophages (41,48,49), suggesting that the M2-like macrophages were present in the fracture 
callus of young mice to a greater extent at earlier time points than in old mice.  The significance 
of this subtle alteration is not known. 
At day 10 we observed increased B-cells in the fracture callus of young mice compared to old 
mice (Fig. 3.2A). During fracture healing B cells regulate osteoclast activity through the expression 
of osteoprotegerin (46), and interactions between B cells and macrophages have been 
demonstrated to regulate inflammation during infection (50,51). While these are intriguing 
observations the specific role of B-cells in mediating effects of age on fracture healing are 
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unexplored, but the novelty of these cells in an inflammatory response to injury is potentially 
interesting.  
The importance of macrophages to fracture healing and bone regeneration is beginning to emerge 
(33,45,52). Different macrophage sub-types have been proposed to mediate separate functions 
during healing.  Pro-inflammatory, or M1-type, macrophages appear early in fracture healing and 
produce pro-inflammatory cytokines (IL-1, IL-6, TNF, iNOS) that further propagate the 
inflammatory response (53).  These cells likely phagocytize remnants of dead tissues to debride 
the fracture site. Later, a switch to anti-inflammatory, or M2-type, macrophages occurs within the 
fracture callus. M2 macrophages initiate down regulation of the inflammatory response with 
production of IL-10 and TGFβ (53,54). M2 macrophages also promote tissue repair through the 
production of growth factors (TGFβ, PDGF, VEGF) (55). However, in vivo phenotyping of 
macrophages is complex, and given the plasticity of macrophages, the M1/M2 distinctions are 
likely not dichotomous and probably represent poles on a large spectrum of macrophage 
phenotypes.  Here, RNA-seq analysis allowed an unbiased analysis of the transcriptomic 
differences of macrophages within the fracture callus of young and old mice. Macrophages from 
the fracture callus of old mice were transcriptionally distinct from macrophages of young mice 
(Fig. 3.3). Further, a M1/M2 gene expression signature, comprised of 14 selected genes for 
cytokines and cell markers associated with traditional M1 and M2 phenotypes, was distinct 
between age groups and able to differentiate macrophages from old mice versus young. Here, 
macrophages from old mice demonstrated expression of more pro-inflammatory or M1 genes 
suggesting that old macrophages contribute to the pro-inflammatory phenotype evident in elderly 
populations. 
With the demonstrated pro-inflammatory, and potentially deleterious, phenotype of aged 
macrophages, we wanted to understand the effect of limiting macrophage recruitment into the 
fracture callus. PLX3397 treatment prevented macrophage recruitment and resulted in improved 
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fracture healing in old mice (Fig. 3.4). The magnitude of change appears small in the PLX3397 
treated old mice when compared to total callus volume at 10 days post fracture. However, the 
change represents a 35% increase in bone volume in the treated group compared to age-matched 
controls, which is consistent with other bone fracture research in mice that shows improvements 
in bone volume within a fracture callus of 25-50% using other experimental agents to improve 
fracture healing (56-58). 
RNA-seq analysis demonstrated that 1222 genes were significantly differently expressed in 
macrophages in old mice compared to young (Fig. 3.3A), and this quantity is important 
considering the breadth of biological and disease processes that these genes are associated with 
(Fig. 3.3B). In old mice, when recruitment of macrophages was inhibited with PLX3397 the 
number of significantly differentially expressed genes between old and young macrophages were 
reduced by 95% (Fig. 3.5B), and the treated old mice clustered between the young and old 
controls (Fig. 3.5C). These findings suggest the presence of a more youthful macrophage 
population after PLX3397 treatment in old mice.  
One potential “youthful” macrophage population is osteomacs. Osteomacs are resident tissue 
macrophages in bone and have been shown to co-localize with osteoblasts and contribute to 
osteogenesis (52,59).  Specific depletion of osteomac populations in vivo was shown to be 
deleterious during both intramembranous and endochondral fracture repair processes (60). After 
inhibition of M-CSF with PLX3397, the infiltrating macrophages were decreased and this is 
accompanied by a decrease in inflammation mediated by macrophages (38,61). The 
pharmacological effect of PLX3397 works largely on infiltrating inflammatory macrophages by 
antagonizing CSF1R and preventing the monocyte to macrophage differentiation. Therefore, we 
suspect that the resident osteomacs are less affected by PLX3397. The improved fracture healing 
in old mice treated with PLX3397 could be a result of decreased inflammatory macrophages 
and/or an expansion or activation of a more youthful and beneficial osteomac population. Further 
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work is needed to understand the age-related changes to osteomacs and their contribution to 
fracture healing.   
A potentially important observation that we made using RNA-seq analysis is that macrophages 
from old animals were much more heterogenous than those from young animals (Fig. 3.3C). The 
heatmaps demonstrated more homogenous gene expression levels between the individual young 
mice than old animals.  The extent of heterogeneity in old mice is present despite all mice being 
from the same genetic background, sourced from the same laboratory and colony, housed in 
similar environments, and samples prepared on the same day. Complex disease processes and 
biological traits, including aging, are often defined by a heterogenous phenotypic presentation 
(62,63,64). Heterogenous changes are present across many aspects of the biology of aging with 
an impact that is not fully understood. Age-related genetic heterogenicity could result from 
cumulative effects from the environment or an unknown mechanism (65).  How to properly 
analyze the heterogenicity present in large genetic datasets is not clearly defined. Largely, the 
heterogeneity is accepted as normal and sample size is increased so that differences may be 
detected. However, further research would be better aimed at understanding the biological cause 
and significance of such variation, as the increased variance in old animals may be a substantial 
contributor to phenotypic outcomes. Further, this may aid in identifying at risk individuals who 
would benefit from individualized treatment plans.    
3.5 Conclusion 
In summary, this study characterizes the cellular immune response during bone fracture healing 
and demonstrates age-related changes at the cellular level that are reflective of the altered 
physiology present in elderly populations.  Robust transcriptional differences differentiated 
macrophages infiltrating the callus of old mice compared to young. The old macrophages 
demonstrated a pro-inflammatory M1 macrophage phenotype. The aged macrophage phenotype 
was detrimental to fracture healing outcomes as fracture healing was improved in old mice when 
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aged macrophages were inhibited from accumulating in the callus during fracture healing. The 
therapeutic targeting of macrophages during fracture healing may be an effective therapy to 
improve fracture healing outcomes in elderly populations.  Finally, understanding the variance 
and its underlying mechanism(s) may contribute significantly to directed treatments of the patient 
with musculoskeletal injuries.   
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Figures: Chapter 3 
 
 
 
Figure 3.1: Old mice demonstrate delayed fracture healing compared to young. (A) 
Representative histological images with Hall Brunt quadruple stain (HBQ) (mineralized tissue 
stains red and cartilage stains blue) of fracture calluses in old (24 months) and young (3 months) 
mice (scale bar= 200um). Stereological analysis was performed and the volume of the total callus 
and the volume of bone and cartilage tissue within the callus was calculated at 10 days after 
closed tibial fracture (n=5/group). (B) Old mice demonstrate delayed healing with smaller callus 
size and significantly less bone and more cartilage (* p<0.05). 
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Figure 3.2: Immune cell infiltration into the fracture callus is similar in old and young mice. (A) 
The quantity of B cells, T cells, NKT cells, and NK cells were similar within the fracture callus at 
days 1, 3, 10 and 14 post fracture measured via flow cytometry in old (n=5) and young (n=5) mice. 
B cell quantity at day 10 was the only significant differences between age groups. (B) 
Macrophages (F4/80+) were the most abundant immune cell analyzed within the fracture callus 
and demonstrated no significant difference in quantity between young (gray) and old (black) mice 
at any of the time points analyzed. (C) A sub-population of macrophages (F4/80+, Ly6C-) was 
increased in young mice at day 1 compared to old mice. (*p<0.005). 
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Figure 3.3: Macrophages from the fracture callus of old mice are transcriptionally distinct from 
young mice.  RNA-seq analysis of callus macrophages in old (n=10) and young (n=11) mice 
collected at 3 days post fracture. (A) 1222 genes were significantly differentially expressed in old 
macrophages compared to young (FDR <0.1) (red dots). (B) Enriched gene ontology terms 
associated with the significantly up and down regulated genes. (C) Heat map demonstrates 
hierarchical clustering of young (yellow) and old (green) mice based on the differential expression 
of the 1222 genes. (D) Hierarchical clustering of young (yellow) and old (green) mice, based on 
the differential expression of a M1/M2 gene signature, demonstrates a more pro-inflammatory/M1 
gene expression signature in macrophages from old mice compared to young. (E) Principal 
component analysis of differential gene expression in macrophages form old mice and young 
demonstrates clustering of young (yellow) mice and a heterogenous spread of old (green) mice 
across PC1 and PC2. 
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Figure 3.4: Inhibition of macrophage recruitment improves fracture healing in old mice.  (A) 
Representative histological images (HBQ stain) of fracture calluses in old mice treated with 
PLX3397 (CSF-1R inhibitor) and aged matched old controls 10 days after closed tibial fracture 
(n=11/group) (scale bar= 200um). Stereological analysis was performed and the volume of the 
total callus and the volume of bone and cartilage tissue within the callus was calculated. (B) Old 
mice treated with PLX3397 demonstrate significantly more bone volume compared to old non-
treated mice (* p<0.05). 
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Figure 3.5: Improved fracture healing in treated old mice is associated with transcriptionally 
“younger” macrophages. (A) PLX3397 treatment during fracture healing resulted in significant 
decrease in macrophage quantity within the fracture callus, as analyzed through flow cytometry. 
(B) RNA-seq analysis demonstrates 64 genes were significantly differentially expressed in old 
macrophages treated with PLX3397 compared to young (red dots) (FDR <0.1). (C) Hierarchal 
clustering demonstrates old macrophages treated with PLX3397 (gray) cluster between young 
(yellow) and old (green) control macrophages. (D) Principal component analysis of differential 
gene expression in macrophages demonstrates close clustering of young (yellow) mice with old 
mice treated with PLX3397 (gray). 
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Supplemental Figure 3.1: Plot of the individual PC scores along PC1 (A) and PC2 (B) of young, 
old, and old mice treated with PLX3397. PC1 separates old from young (A).  The variance of PC 
scores is greater across both PC1 and PC2 in old mice compared to young. (C) Scree plot 
demonstrates that the majority of the variance (56.9%) is accounted for in PC1 and PC2.   
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Supplemental Table 3.1: Gene list of the upper and lower 2% of eigenvalues along PC1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Upper 2% 
 
Lower 2% 
Gene Eigenvalue 
 
Gene Eigenvalue 
Igkv15-103 0.0584 
 
Gpnmb -0.0425 
Ighg2c 0.0556 
 
Selenop -0.0426 
Ighv7-1 0.0547 
 
Slc6a8 -0.0428 
Igkc 0.0537 
 
P2ry6 -0.0429 
Ighg2b 0.0531 
 
Pdlim4 -0.0432 
Igkj5 0.0439 
 
Tppp3 -0.0436 
Ighv6-3 0.0435 
 
Lpl -0.0437 
Igkv5-39 0.0430 
 
Fcgr1 -0.0440 
Igkv1-117 0.0426 
 
Cav1 -0.0443 
BC100530 0.0426 
 
Igf1 -0.0445 
Stfa2l1 0.0425 
 
Pid1 -0.0446 
Igkv1-88 0.0418 
 
Tmem37 -0.0447 
Igkv6-32 0.0388 
 
H2-Ab1 -0.0448 
Asprv1 0.0385 
 
Cx3cr1 -0.0449 
Stfa2 0.0383 
 
Gdf15 -0.0449 
Igkj2 0.0368 
 
Il10 -0.0449 
Ighv14-2 0.0356 
 
Mmp14 -0.0450 
Aspa 0.0351 
 
Ednrb -0.0451 
Stfa1 0.0343 
 
H2-Aa -0.0452 
Ighv11-2 0.0343 
 
Ifi27l2a -0.0453 
Gm5483 0.0335 
 
C3ar1 -0.0458 
Pou2af1 0.0334 
 
H2-Eb1 -0.0461 
Iglc2 0.0325 
 
Ccr5 -0.0465 
Igha 0.0323 
 
Stab1 -0.0468 
Ighj4 0.0322 
 
Olfml3 -0.0469 
Ighv5-16 0.0316 
 
Aif1 -0.0477 
Hoxa9 0.0309 
 
Emp1 -0.0477 
Ctla2a 0.0309 
 
Amz1 -0.0482 
Cacna1h 0.0307 
 
Abcc3 -0.0483 
Gm27252 0.0305 
 
Pmp22 -0.0487 
Ighm 0.0301 
 
Apoe -0.0489 
Gimap6 0.0301 
 
Pltp -0.0489 
D630045J12Rik 0.0298 
 
Cd36 -0.0494 
Stfa3 0.0297 
 
Spp1 -0.0495 
Il5ra 0.0296 
 
Ccl12 -0.0497 
Hoxa7 0.0288 
 
Dab2 -0.0497 
Fam110c 0.0287 
 
Gas6 -0.0497 
Saa3 0.0287 
 
Ifi205 -0.0498 
Pdgfrb 0.0286 
 
Nxpe5 -0.0500 
Dmwd 0.0284 
 
Lgmn -0.0507 
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Supplemental Table 3.1 (cont.): Gene list of the upper and lower 2% of eigenvalues along PC1 
  Upper 2%  Lower 2% 
Gene Eigenvalue  Gene Eigenvalue 
Spns2 0.0284 
 
Ccl8 -0.0519 
Mpl 0.0279 
 
Pf4 -0.0520 
Igkj4 0.0279 
 
Flrt3 -0.0524 
Cxcr2 0.0278 
 
C1qc -0.0526 
Ighj2 0.0277 
 
Folr2 -0.0527 
Iglv1 0.0277 
 
Siglec1 -0.0539 
Retnlg 0.0274 
 
Ms4a14 -0.0539 
Igkv5-43 0.0273 
 
Cxcl1 -0.0545 
Il17rb 0.0273 
 
Ppbp -0.0548 
Ighv9-3 0.0270 
 
Sdc3 -0.0551 
Scrg1 0.0269 
 
C1qb -0.0558 
Ighj1 0.0268 
 
Cbr2 -0.0570 
Ighv1-15 0.0266 
 
Pdpn -0.0582 
Myct1 0.0265 
 
Arg1 -0.0589 
Crispld2 0.0265 
 
C1qa -0.0596 
Muc13 0.0265 
 
Ccl7 -0.0598 
Cd55 0.0265 
 
Cd209a -0.0598 
Epx 0.0264 
 
Ms4a7 -0.0610 
Itga2b 0.0263 
 
Mrc1 -0.0656 
Serpina3g 0.0263 
 
Fcrls -0.0737 
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Chapter 4: Age-related changes to macrophages contribute to the pathogenesis of 
periodontal disease 
4.1 Introduction 
Periodontal disease results from a dysbiosis between the bacterial plaque and the host 
inflammatory response (1).  In disease, the host inflammatory response results in the osteolytic 
destruction of bone supporting the teeth, which is the clinical hallmark of periodontal disease (1,2). 
Management of periodontal disease involves, in part, controlling the presence of bacterial plaque. 
However, adequate management of the host inflammatory response remains elusive. 
Susceptibility to periodontal disease is typically associated with systemic inflammatory 
dysregulation (3).  Obesity, type II diabetes, rheumatoid arthritis, and Alzheimer’s disease are 
associated with a higher incidence of periodontal disease, and each disease presents with an 
underlying perturbation of inflammation that predisposes or directly contributes to the 
pathogenesis of the disease (3,4).  The elderly population is an additional group that demonstrate 
systemic inflammatory dysregulation. Inflamm-aging, as described in previous chapters, 
describes the elevated chronic inflammatory status of the elderly (4). This dysregulated 
inflammatory status in the elderly appears to contribute to the pathogenesis of periodontal 
disease, as increased prevalence of periodontal disease is associated with increased age (5,6).   
The focus of this work was to investigate the macrophage due to its shared contribution to 
inflamm-aging as well as to the pathogenesis of periodontal disease.  As reviewed in Chapter 2, 
the macrophage contributes to periodontal disease via the M1/pro-inflammatory macrophage 
phenotype that presents within the periodontium in response to the presence bacterial plaque.  
Persistence of the M1 phenotype or lack of the M2/anti-inflammatory phenotype contributes to 
the pathogenesis of periodontal disease (7,8).  Our work in Chapter 3 demonstrates distinct 
transcriptional differences of macrophages from old mice compared to young and characterizes 
an age macrophage phenotype as being more M1 and pro-inflammatory.  From this data, we 
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hypothesized that the aged macrophage phenotype would be detrimental in the proper regulation 
of inflammation and contribute to the pathogenesis of periodontal disease.  
4.2 Materials and Methods 
4.2.1 Periodontal disease induction 
All animal procedures were approved by the UCSF Institutional Animal Care and Use Committee. 
Old (24-month) and young (3-month) male C57BL/6 mice were obtained from the NIA Aging 
Rodent Colony. Periodontal disease induction was accomplished by first anesthetizing the mice 
with a 1:1 solution of dexmedetomidine and ketamine delivered IP. Then a 6.0 silk suture 
inoculated with Porphyromonas gingivalis (ATCC 33277) was tied in a subgingival position around 
the second maxillary molars bilaterally. Control mice in both age groups received a sham surgery 
where mice were anesthetized, sterile sutures were placed subgingivally and then immediately 
removed. The sutured remained in place for 7 days to adequately induce periodontal disease.  At 
the end of the 7-day induction period mice were euthanized, or in a second arm of the study, the 
sutured was removed and the animal was allowed to recover for an additional 7 days.  At the end 
of disease induction or disease recovery period, animals were euthanized, and maxillae were 
collected for analysis.   
4.2.2 Macrophage depletion 
During disease induction or disease recovery, half the mice in each age group received a 
pharmacologic, PLX3397 (Plexxikon, Berkeley, CA), to deplete macrophages within the 
periodontium.  PLX3397 was delivered throughout the 7-day period via mouse chow ad libitum at 
an average dose of 40mg/kg/day. PLX3397 is a small molecule inhibitor of the macrophage 
colony stimulating factor 1 (MCSF-1) receptor. Antagonizing the MCSF-1 receptor prevents 
differentiation of monocytes into macrophages and subsequent recruitment to the site of 
inflammation. Non-treated groups received the control chow provided by the drug manufacturer. 
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4.2.3 Micro-CT analysis 
Primary outcomes of disease severity were determined by bone volume/total volume and bone 
mineral density as measured via micro-CT.  Dissected maxillae were separated into the left and 
right alveolar processes. One hemimaxilla had the gingiva removed (used for qRT-PCR analysis) 
and the alveolar process containing the 3 molar teeth was isolated, defleshed, and soaked in 30% 
hydrogen peroxide overnight to allow for complete removal of the soft tissue. The alveolar 
processes were fixed in 10% buffered formalin. Samples were scanned using Scano Medical µCT 
set at 55kVp and 109µA with a slice thickness of 5µm.  Analysis of the scanned images was 
performed using Scanco Medical µCT Evaluation Program v6.5. The region of interest was 
delineated along transverse slices isolating alveolar bone supporting teeth and excluding tooth 
structure. Mesial and distal boundaries were made at the buccal furcation of the first molar and 
the buccal furcation of the third molar. 
4.2.4 qRT-PCR 
Inflammatory cytokine expression within the gingiva was compared across treatments and age 
groups via qRT-PCR. Gingiva was isolated from one half of the dissected maxilla and prepared 
for qRT-PCR analysis. Briefly, gingiva was homogenized in Trizol and mRNA was isolated. cDNA 
was reverse transcribed using Superscript III (Invitrogen). qRT-PCR was performed with SYBR 
Green and the following primers; GAPDH (F: 5'-AGCCTCGTCCCGTAGACAAAAT-3'; R: 5'-
CCGTGAGTGGAGTCATACTGGA-3'), IL-1β (F: 5’-TGTAATGAAAGACGGCACACC-3’; R: 5’-
TCTTCTTTGGGTATTGCTTGG-3’), TNFα (F: 5’-TGCCTATGTCTCAGCCTCTTC-3’; R: 5’-
GAGGCCATTTGGGAACTTCT-3’), IL-6 (F: 5’-TCCAATGCTCTCCTAACAGATAAG-3’; R: 5’-
CAAGATGAATTGGATGGTCTTG-3’), IL-17 (F: 5’-GCTCCAGAAGGCCCTCAGA-3’; R: 5’-
CTTTCCCTCCGCATTGACA-3’), IL-23 (F: 5′-TGTGCCCCGTATCCAGTGT-3; R: 5′-
CGGATCCTTTGCAAGCAGAA-3′), iNOS (F: 5’-GAAGGGGACGAACTCAGTGG -3’; R: 5’- 
GTGGCTCCCATGTTGCATTG -3’), TREM2 (F: 5'-AAAGTACTGGTGGAGGTGCTG-3'; R: 5'-
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AGGCTAGAGGTGACCCACAG-3'). Gene expression was normalized to the house keeping gene 
GAPDH and presented as relative gene expression (ΔΔCT) or fold change (2-ΔΔCT). 
4.2.5 Immunohistochemistry  
Quantification of macrophages within the periodontium was performed via immunohistochemical 
staining for F4/80+ macrophages. One half of the maxilla was isolated and fixed in 4% 
paraformaldehyde for 24 hours. The tissue was then decalcified with 19% 
ethylenediaminetetraacetic acid (pH 8) for 28 days with the solution changed every other day. 
After complete decalcification, the samples were dehydrated and embedded in paraffin. Paraffin 
sections were cut with a microtome at 8 micrometers thick and prepared for staining. Sections 
were first blocked with 3% H2O2  (45 minutes), followed by antigen retrieval with Trypsin 0.1% in 
dH2O for 30 minutes. Sections were then blocked with 5% goat serum albumin for 1 hour.  The 
primary antibody, rat anti-mouse F4/80 (BD Biosciences), was incubated with the section at a 
1:200 dilution (in 5% goat serum) overnight at 4ºC. The secondary anti-body, HRP conjugated 
goat anti-mouse IgG, was applied at 1:500 dilutions and incubated for 1 hour.  Secondary antibody 
signal was amplified using the VectaStain ABC Kit (Vector) and finally stained with 3,3’-
diaminobenzidine (DAB) substrate. Photographs were taken of one representative slide at 200x, 
and 3 regions of interest (ROI) per slide were analyzed at 400x.  The ROIs were adjacent to the 
tooth and included the epithelium, connective tissue or bone in the coronal 1/3 of the root. Each 
ROI had a field of view (FOV) of 0.23mm². F480+ macrophages were quantified using Image J 
imaging software. The 3 ROIs were averaged per sample for each mouse. 
4.2.6 Statistical Analysis 
The BV/TV, BMD, and macrophage quantification was calculated per sample and presented as 
mean±SD. Groups were first analyzed via ANOVA for significant differences, and between group 
differences were analyzed using a two tailed T-test. qRT-PCR utilized technical triplicates and the 
mean QT value was calculated.  Relative gene expression (ΔΔCT) was calculated and presented 
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as mean±SEM and analyzed using an ANOVA followed by between group comparisons using a 
two-tailed T-Test. Significance for all analysis was determined at p<0.05.  All statistical analysis 
was performed using GraphPad Prism v.7 software. 
4.3 Results 
4.3.1. Old mice demonstrate an aged periodontal phenotype 
Alveolar bone height was compared in old (24 month) and young (3 month) healthy control mice 
(n=5/group). Old mice demonstrated significantly increased bone loss (0.19mm±0.007)) 
compared to young (0.09mm±0.015) (p<0.01) (Fig. 4.1).  Increased bone loss in control old mice 
was associated with inflammatory dysregulation within the gingiva. IL- 1β, TNFα, IL-6, IL-17 
demonstrated significant increased expression in the gingiva of old control mice compared to 
young (p<0.05) (Fig. 4.1). 
4.3.2. Macrophage quantity within the periodontium is similar in old and young mice. 
The ligature model of periodontal disease resulted in significant bone loss in old and young mice 
after an induction period of 7 days (Fig. 4.2).  Macrophage quantification was analyzed in old and 
young mice (n=5/group) at three time points; baseline, after 7 days of disease induction, and after 
7 days of recovery.  At all time points, the macrophage quantity within the periodontium was 
similar in old and young mice (p>0.05) (Fig. 4.2).   
4.3.3. Macrophage depletion attenuates bone loss and pro-inflammatory cytokine expression in 
old and young mice 
Periodontal disease was induced in old and young mice (n=5/group). Half the mice in each group 
received PLX3397.  Administration of PLX3397 throughout the induction period resulted in a 
significant decrease in macrophage quantity within the periodontium of old and young mice 
(p<0.05) (Fig. 4.3).  In old mice, treatment with PLX3397 resulted in significantly increased bone 
volume/total volume compared to non-treated controls (61±3% vs 53±3%) (p<0.001) and 
significantly increased bone mineral density compared to non-treated controls (822±51mg 
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HA/mm3 vs 707±58 mg HA/mm3) (p<0.001) (Fig. 4.3). Improved bone measurements with 
PLX3397 treatment was associated with decreased inflammatory cytokine expression.  Treated 
old mice demonstrated significant decreases in relative mRNA expression of IL-1β, TNFα, and 
IL-6 (p<0.05) (Fig. 4.3).  In young mice, a similar trend was also demonstrated. During disease 
induction in young mice, treatment with PLX3397 resulted in significantly increased bone 
volume/total volume compared to non-treated controls (59±0.4% vs 46±1.0%) (p<0.001) and 
significantly increased bone mineral density compared to non-treated controls (776±7mg HA/mm3 
vs 598±20 mg HA/mm3) (p<0.001) (Fig. 4.3). Relative mRNA expression of iNOS was significantly 
reduced in young mice with treatment compared to non-treated controls (p<0.05) (Fig. 4.3). 
4.3.4. During disease recovery, macrophage inhibition differentially affects bone loss and pro-
inflammatory cytokine expression in old compared to young mice. 
PLX3397 administration in old mice during disease recovery demonstrated similar significant 
improvements as was seen during disease induction. Treatment in old mice resulted in 
significantly increased bone volume/total volume compared to non-treated controls (62±2% vs 
56±2%) (p<0.05) and significantly increased bone mineral density compared to non-treated 
controls (815±37mg HA/mm3 vs 750±33 mg HA/mm3) (p<0.001) (Fig. 4.4). Relative mRNA 
expression of IL-1β was also significantly decreased within the gingiva of treated mice compared 
to non-treated controls (p<0.05) Fig. 4.4).  However, in young mice, no benefit of PLX3397 
administrated was demonstrated during disease recovery.  Compared to non-treated controls, 
treated young mice demonstrated no significant differences in bone volume/total volume (54±1% 
vs 55±1%) (p>0.05) or bone mineral density (690±26mg HA/mm3 vs 709±28 mg HA/mm3) 
(p>0.05). There were also no significant differences in the relative mRNA expression of the 
inflammatory genes analyzed in young treated mice compared to non-treated controls during 
disease recovery (p>0.05) (Fig. 4.4). 
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4.4 Discussion 
The results from this work support the role of macrophages in periodontal disease pathogenesis 
and further demonstrate age-related changes to the macrophage as a contributing factor to the 
increased prevalence of periodontal disease in elderly populations.  
We demonstrated an aged periodontal phenotype in old mice with increased bone loss and 
associated increased pro-inflammatory cytokine expression.  This periodontal phenotype is 
represented in humans that demonstrate increased prevalence of periodontal disease with age 
and an associated systemic inflammatory dysregulation (4,5).  The systemic inflammatory 
dysregulation is known as inflamm-aging and has been associated with the myriad of age-related 
disease (9).  Other groups have similarly shown that periodontal disease in mice increases with 
age (10).  However, specific mechanisms responsible for the age-related increased in disease 
prevalence are unknown. 
Our group decided to investigate the macrophage in the context of aging and periodontal disease 
after understanding the age-related changes that occur to macrophages involved in fracture 
healing, as presented in Chapter 3.  Macrophages were demonstrated to be transcriptionally 
distinct in the fracture callus of an old mouse compared to young as measured via RNA-seq. Both 
periodontal disease and fracture healing can be considered osteoimmunological models to study 
macrophages.  In both models, local sites of inflammation affecting bone result in the recruitment 
and infiltration of macrophages, and the necessary resolution of inflammation depends, in part, 
on a change in macrophage activity or phenotype (11). In the periodontal disease model, the 
stimulus is bacterial in nature, while the fracture model exhibits “sterile” inflammation without a 
bacterial or infectious component.  It would be assumed that the macrophage activity would differ 
in some aspects with and without the presence of bacteria.  However, we contend that the 
extensive transcriptional differences between macrophages in old versus young fracture calluses 
can be compared across osteoimmunological models. The increased pro-inflammatory and M1 
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gene expression by macrophages within the fracture callus of old mice would be similarly 
pathogenic in periodontal disease and could contribute to the increased prevalence and severity 
of periodontal disease associated with increased age. 
We have demonstrated the quantity of infiltrating macrophages into the periodontium did not differ 
by age group.  The quantity of macrophages at baseline, after 7 days of disease induction, and 
after 7 days of disease recovery were similar in the periodontium of both old and young mice.  
These findings demonstrate that age related changes do not result in differential recruitment or 
substantivity of the macrophage at the site of inflammation.  Certainly, a prolonged or stronger 
signal resulting in increased recruitment of inflammatory cells could result in more severe disease 
presentation.  However, the increased prevalence of disease in old mice does not appear to be a 
result of increased macrophages present within the periodontium.  Our previous findings 
demonstrated similar macrophage numbers in the fracture callus of old and young mice (Chapter 
3).  Taken together, these findings suggest the demonstrated transcriptional differences in old 
and young macrophages are an important contributing factor to the pathogenesis of periodontal 
disease in old mice.   
The depletion of macrophages during periodontal disease induction resulted in decreased 
disease severity in both young and old mice.  The decreased disease severity was associated 
with decreased inflammatory cytokine expression locally within the gingiva.  Other groups have 
shown similar improvements in periodontal disease severity with the administration of compounds 
that targetd the inflammatory response.  Alveolar bone loss was significantly reduced in a mouse 
model of periodontal disease by local delivery of a cytokine (CL22) that increased the local 
recruitment of T regulatory cells (12). Similarly, promoting the resolution of inflammation in a 
mouse model of periodontitis with the administration of resolvins resulted in decreased bone loss 
(13). 
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It was interesting to see a benefit with macrophage depletion during disease recovery in old mice 
but not in young.  We hypothesize this differential effect by age was due to the transcriptional 
difference demonstrated in old mice compared to young.  Macrophages from old mice 
demonstrated more M1 and pro-inflammatory cytokine gene expression (Chapter 3).  Therefore, 
depleting the old macrophages reduced a source of cytokines that could propagate the 
inflammatory response.  However, when young macrophages were depleted, there was not the 
same reduction of pro-inflammatory cytokines.  We hypothesize that the young macrophage had 
already made the phenotypic switch to an M2-like macrophage during the recovery phase. Thus, 
less of a benefit was demonstrated by depleting M2-like macrophages in young mice compared 
to depleting M1-like macrophages in old mice.  From the analyses here, it is unknown if there was 
a deleterious effect from depleting M2-like macrophages in young mice. The M2 phenotype is 
involved in inflammatory resolution as well as producing growth factors to aid in tissue healing 
(11). Therefore, it could be reasoned that the depletion of M2 macrophages may be detrimental 
during recovery from periodontal disease.  Our micro-CT data demonstrate a minimal reduction 
in bone volume/total volume and bone mineral density in the treated young mice compared to the 
non-treated controls during disease recovery.  These findings were far from statistically 
significant; however, additional quantitative methods or macrophage depletion over a longer 
period of time may demonstrate the potential detrimental effect of depletion of M2-like 
macrophages. 
We demonstrated the administration of PLX3397 significantly reduced the number of 
macrophages within the periodontium.  Multiple macrophage depletion strategies exist that could 
be applied in a similar manner to a periodontal disease mouse model.  Clodronate liposomes can 
be administered to deplete macrophages. The liposomes are phagocytized by the macrophages 
and the clodronate is delivered intracellularly and results in apoptosis of the cell (14).  This method 
has similarly shown effective depletion rates of macrophages within bone (15), but it first requires 
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the presence of a differentiated and active mature macrophage. Thus, by first allowing the 
differentiation of the macrophage at the site of inflammation, cytokine secretion activity could 
already have an effect on the disease process before the macrophage is depleted.  Another 
macrophage depletion strategy utilizes the transgenic MaFIA mouse (Mac Fas-inudced 
apoptosis). The MaFIA mouse used a Cre-loxP system to target the Csfr1r promoter that allows 
for inducible apoptosis upon administration of diphtheria toxin (16). The MaFIA mouse system is 
similarly effective in depleting macrophages but lacks specificity and targets other CD11b cells 
that may result in confounding effects in periodontal disease (17).  Similarly, PLX3397 may have 
an effect on cells other than macrophages.  By antagonizing the m-CSF receptor, the drug blocks 
monocyte differentiation of other cell types that require M-CSF activation.  These other cell types 
importantly include osteoclasts which would be involved in the pathogenesis of periodontal 
disease.  In examining the activity of osteoclasts during periodontal disease, we found TRAP+ 
cells present in the periodontium of PLX3397 treated mice similar to what was observed in non-
treated mice (Supplementary Figure 4.1).  The difference in quantity of osteoclasts between 
treated and non-treated mice could not be specifically associated as a direct effect of the drug, 
as PLX3397 administration also reduced expression of inflammatory cytokines that are upstream 
of osteoclast activation (18).   
4.5 Conclusion 
The work presented here demonstrates that the aged macrophage phenotype, as characterized 
in Chapter 3 via RNA-seq, contributes to the pathogenesis of periodontal disease.  Similar 
beneficial outcomes were demonstrated from macrophage depletion in aged models of fracture 
healing and periodontal disease, suggesting the age-related changes to macrophages strongly 
contribute to the inflamm-aging phenotype in an orthopaedic context.  Interestingly, the beneficial 
outcome demonstrated from macrophage depletion during disease recovery could serve as a 
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model for a more directed therapeutic strategy for the management of periodontal disease in the 
elderly population.  
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Figures: Chapter 4 
 
 
Figure 4.1: Old mice present an aged periodontal phenotype. Bone loss in healthy control old 
mice is associated with increased pro-inflammatory gene expression. Linear bone loss (measured 
from CEJ to alveolar bone crest-red line) in old mice (24 month) (A) was compared to young mice 
(3 month) (B), and quantified (C).  Fold change of gene expression in gingiva of old relative to 
young (D). (*p<0.05). 
 
 
 
 
 
 
 
Young Old 
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Figure 4.2: Macrophage quantity within the periodontium is similar in old and young mice.  
Disease induction via the ligature model (A) resulted in significant bone loss compared to control 
mice in young (3 month) and old (24 month) mice (B).  Macrophage quantity within the 
periodontium was measured via immunohistochemistry for F4/80+ macrophages (brown) (C). The 
quantity of macrophages within the periodontium at baseline, after 7 days of disease induction, 
and after 7 days of disease recovery was not significantly different in young and old mice (D).  
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Figure 4.3: Macrophage depletion attenuates bone loss and pro-inflammatory cytokine 
expression in old and young mice.  After 7 days of disease induction dissected hemi-maxillae 
were analyzed via micro-CT from old (A) and young (D) mice. Treated groups received 
PLX3397 throughout the induction period to deplete macrophages.  Control groups received a 
control chow.  As a measure of disease severity bone mineral density (BMD) and bone 
volume/total volume (BV/TV) were analyzed via micro-CT in old (B) and young mice (E) as a 
function of macrophage depletion treatment.  Gingiva was removed from the hemi-maxillae and 
analyzed via qRT-PCR for expression of pro-inflammatory cytokines.  Relative mRNA 
expression (ΔΔCT) was compared between treated and control group in old (C) and young (F) 
mice. (*p<0.05, **p<0.001). 
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Figure 4.4: During disease recovery, macrophage inhibition differentially affects bone loss and 
pro-inflammatory cytokine expression in old compared to young mice.  After 7 days of disease 
recovery dissected hemi-maxillae were analyzed via micro-CT from old and young mice. 
Treated groups received PLX3397 throughout the recovery period to deplete macrophages.  
Control groups received a control chow.  As a measure of disease severity bone mineral density 
(BMD) and bone volume/total volume (BV/TV) were analyzed via micro-CT in old (A) and young 
mice (C) as a function of macrophage depletion treatment.  Gingiva was removed from the 
hemi-maxillae and analyzed via qRT-PCR for expression of pro-inflammatory cytokines.  
Relative mRNA expression (ΔΔCT) was compared between treated and control group in old (B) 
and young (D) mice. (*p<0.05, **p<0.001). 
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Supplemental Figure 4.1: Osteoclastogenesis is present after PLX3397 treatment. TRAP 
staining of histological slides of the periodontium in mice after 7 days of periodontal disease 
induction (A), after 7 days of periodontal disease induction with administration of PLX3397 
throughout the induction period (B) and in healthy controls (C). (20x magnification)  
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Chapter 5: Mechanisms driving inflammatory dysregulation in aged macrophages 
5.1 Introduction 
The previous work has robustly demonstrated the age-related changes that occur to the 
macrophage at the transcriptional level and has characterized an aged macrophage phenotype 
with increased M1/pro-inflammatory gene expression.  Further, it has shown how depletion of the 
aged macrophages has beneficial effects in two distinct osteoimmunological models, fracture 
healing and periodontal disease.  The goal of the proceeding work was to further understand 
mechanisms driving the age-related changes in macrophages and to understand the effect of the 
aged macrophage phenotype on other inflammatory cells during fracture healing and periodontal 
disease. Therefore, we have investigated age-related changes to the expression of triggering 
receptor expressed on myeloid cells (TREM2) that may contribute to the differential inflammatory 
gene expression in aged macrophages. Further, we investigated how the aged macrophage 
phenotype may promote other downstream cellular regulators of inflammation. 
Regulation of macrophages activity occurs, in part, through the activity of TREM2. Activation of 
TREM2 on macrophages results in downregulation of inflammation (1).  TREM2 signals through 
its transmembrane coreceptor DNAX-activation protein 12 (DAP12) to inhibit TLR stimulation of 
pro-inflammatory cytokines production (2) (Fig. 5.1). Studies have demonstrated that inhibition of 
TREM2 results in increased pro-inflammatory cytokine production and increased inflammatory-
related damage to tissue (3,4).  Despite being an attractive target to regulate inflammation, no 
natural ligand of TREM2 has been discovered (1). Polymorphisms of TREM2 gene can result in 
a condition known as polycystic lipomembranous osteodysplasia with sclerosing 
leukoencephalopathy (PLOSL), which presents with bone cysts, osteoporotic features, and 
neurodegeneration possible due to a systemic wide disturbance in inflammatory regulation (5). 
The role of TREM2 in an osteoimmunological context has not been previously investigated.  Our 
genetic understanding of PLOSL and the associated bone cysts suggest TREM2 may be involved 
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in inflammatory regulation within the skeletal system.  Previous work has shown that knockout of 
Dap12 has been shown to be detrimental in fracture healing in mice (6). Understanding the 
mechanisms of how TREM2 regulates inflammation within bone and the effect of age on TREM2 
is import for the improved management of disease and conditions within elderly populations.    
The effects of the aged macrophage phenotype on other immune cells are unknown.  Given the 
increased pro-inflammatory cytokine gene expression demonstrated by aged-macrophages, it is 
reasonable to assume other immune cells in the inflammatory cascade may be differentially 
affected by aged macrophages compared to young. One potential pathogenic cellular interaction 
in periodontal disease is between the macrophage and Th17 cells.  Th17 cell expansion and IL-
17 expression are pathogenic mediators in periodontal disease (7,8). There are multiple cellular 
sources of IL-17 within the gingiva; however, during periodontal disease Th17 cells represent 
80% of the IL-17+ cells (7). Inhibition of Th17 cell differentiation was shown to decrease disease 
severity (7). Drivers of pathogenic Th17 cell expansion in periodontal disease are beginning to be 
elucidated but are not fully understood. Pathogenic expansion of Th17 cells requires IL-6 and IL-
23 signaling (7,8). With increased age, Th17 cells demonstrate increased homeostatic expansion 
(9); however, it is unknown the extent to which pathogenic Th17 cell expansion is differentially 
regulated by age. Understanding how the aged macrophage phenotype may drive pathogenic 
Th17 expansion may lead to potential therapeutic targets.   
5.2 Materials and Methods 
The methodology is described in brief below with full descriptions included in the previous 
chapters.   
5.2.1. Animals 
All procedures were approved by the UCSF Institutional Animal Care and Use Committee and 
conducted in accordance with the National Institutes of Health guidelines for humane animal care. 
Mice (C57B6/J) were obtained from the National Institute on Aging’s Aged Rodent Colony. 
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Specific pathogen-free mice were bred and raised in barriers and utilized for experiments at 24 
months (old adult mice) or 3 months (young adult mice) of age. Trem2 knockout mice were 
generated, authenticated, and provide by our collaborator Mary Nakamura.  
5.2.2. Tibia fractures 
Mice were anesthetized and subjected to closed, non-stable fractures of the right tibia created by 
three-point bending, as previously described (10). To inhibit macrophage recruitment during 
fracture healing in old mice, treatment groups received the compound PLX3397 (275mg/kg) 
(Plexxikon Inc. Berkeley, CA) ad libitum in their chow. Control groups received the same chow 
without PLX3397. Treatment with PLX3397 was started 24 hours before fracture and continued 
for 3 or 10 days after fracture until the animal was euthanized and the tissues harvested for 
analysis.  
5.2.3. Tibia processing and stereology 
Mice were sacrificed at day 10-post fracture for stereological analysis of the fracture callus.  
Fractured tibiae were collected, fixed, and decalcified. Serial sagittal sections (10μm) were 
mounted on slides and stained using Hall Brunt Quadruple Stain (HBQ) to visualize bone and 
cartilage. Total callus, bone and cartilage volume was quantified according to stereological 
methods developed by Howard and Reed (11).  
5.2.4. Flow cytometry 
Old and young mice were sacrificed at day 3 post fracture.  Fractured tibiae were collected and 
the calluses were dissected and digested with Collagenase type I (0.2mg/mL; Worthington, 
Lakewood, NJ) for 1 hour at 37 degrees.  Cells were isolated and resuspended in incubation 
buffer (0.5% BSA in PBS).  Isolated cells were blocked and then stained with directly conjugated 
fluorescent antibodies: CD45 (clone 30-F11), CD3 (145-2C11), B220 (RA3682), Gr-1 (RB6-8C5),  
NK1.1 (PK136), MHC Class II (M5/114.15.2) Ly6 C (HK1.4) Ly6G (clone 1A8), F4/80 (clone BM8), 
and CD11b (clone M1/70) (Biolegend, San Diego, CA). Cells were sorted on a FACSAria (BD 
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Biosciences, San Jose, CA), and FlowJo Software 9.6 (Treestar, Ashland, OR) was used for 
analysis.  
5.2.5. RNA-seq Analysis 
Macrophages were isolated from the fracture callus of old (n=10) and young (n=11) mice at day 
3 post-fracture. The callus was dissected and cells were collected and stained as described 
above.  Macrophages were collected by staining with CD45 (clone 30-F11), F4/80 (clone BM8), 
and CD11b (clone M1/70) (Biolegend, San Diego, CA). RNA was extracted using Invitrogen RNA 
aqueous Micro Kit (AM1931). The library was prepared and Single-end 50 bp RNAseq was 
performed on Illumina HiSeq 4000. Reads were aligned using STAR_2.4.2a to the mouse 
genome (Ensemble Mouse GRCm38.78). Differential gene expression was assessed using 
DEseq2. Gene ontology and KEGG pathway analysis was performed using DAVID 
(http://david.abcc.ncifcrf.gov) and the mouse genome was used as background.  
5.2.6 qRT-PCR 
Five days post fracture, the animal was sacrificed and the whole callus was dissected.  Similarly, 
7 days after periodontal disease induction (see chapter 3 for disease induction methodology) or 
in healthy controls, gingival tissue was dissected bilaterally from the maxillary alveolar process. 
Dissected tissue was placed in Trizol and homogenized.  RNA extraction was then performed 
with isopropanol.  cDNA was synthesized and quantitative real time PCR was performed on 
biological and technical triplicates.  Relative gene expression of IL-1β, IL-6, TNF-α, iNOS, IL-23 
was quantified. GAPDH was used as the house keeping gene. 
5.2.7. Statistics 
GraphPad Prism v.7 software was used for analysis. Comparisons between groups was made by 
first using a 2-way ANOVA multiple comparisons test followed by a 2-tailed Student’s t test. 
P<0.05 was considered statistically significant. Differential gene expression was considered 
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significant at FDR<0.1. For term enrichment in gene ontology and KEGG pathway analysis the 
level of significance was set using a modified Fisher Exact P-value of p<0.05. 
5.3 Results  
5.3.1 TREM2 is upregulated during fracture repair 
Three days after tibia fracture in old and young mice, the fracture callus was dissected, and 
macrophages were isolated.  Isolated macrophages were Cd45+, and CD11b+, and further 
analyzed for expression of F4/80+.  Additionally, macrophages were isolated from non-fractured 
bone marrow of old and young mice as controls for comparison.  Figure 5.2 demonstrates that 
TREM2 expression is nearly absent in macrophages from the non-fractured bone marrow of old 
and young mice, suggesting in the absence of an inflammatory process, TREM2 is not active.  
However, the lower panels demonstrate an increase in TREM2 expression on macrophages 
isolated from the fracture callus.  There also appears to be a trend towards increased TREM2 
expression in the macrophages from young mice compared to old.    
5.3.2 TREM2 is downregulated in old mice compared to young  
To understand how TREM2 expression on macrophages is affected by age, macrophages were 
collected from the fracture callus of old and young mice 3 days after fracture and analyzed via 
bulk RNA-seq.  Figure 5.3 demonstrates the list of genes involved in the TREM2 signaling 
pathway.  Of all the genes involved, only TREM2 expression was significantly differentially 
affected by age (FDR<0.1), with decreased expression in the old macrophages compared to 
young.  Further, when periodontal disease was induced in old and young mice, TREM2 
expression was significantly lower within the gingiva of old mice compared to young (Fig. 5.3). 
5.3.3 TREM2 deficient mice demonstrate increased pro-inflammatory cytokines expression in the 
fracture callus and in the gingiva  
To understand the impact of TREM2 in regulating inflammation, we obtained mice with genetic 
deletion of TREM2.  Gingival tissue was dissected from TREM2-/- mice and aged matched wild 
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type controls. Pro-inflammatory cytokine expression was increased in TREM2-/- mice compared 
to controls (Fig. 5.3).  Similarly, fractures were created in TREM2-/- and aged-matched wild type 
controls and the calluses were isolated five days pose fracture.  Analysis of the fracture callus via 
qRT-PCR similarly demonstrated increased pro-inflammatory cytokine expression in the fracture 
callus of TREM2-/- mice compared to controls (Fig. 5.4) 
5.3.4 TREM2 deficient mice demonstrate delayed fracture healing 
As TREM2 deficiency drove inflammatory dysregulation in the fracture callus, we wanted to 
understand the impact of TREM2 deficiency on fracture healing outcomes.  Tibia fractures were 
created in Trem2-/- mice and wild type controls. Animals were sacrificed and the healing callus 
analyzed after 7, 10, and 14 days post fracture.  Calluses were analyzed via stereology to quantify 
the volume of total callus, bone and cartilage tissue.  Trem2-/- mice demonstrated significant 
delayed healing by day 10 with significantly decreased callus volume and bone volume compared 
to wild type controls (Fig. 5.4).   
5.3.5 An aged macrophage phenotype may drive Th17 cell expansion to further promote 
inflammatory dysregulation in periodontal disease. 
The pathogenesis of periodontal disease involves, in part, activation and expansion of Th17 cells 
locally within the gingiva.  Th17 cell expansion is driven by activation by IL-6 and IL-23. The 
specific tissue and cellular sources of IL-6 and IL-23 that drive Th17 cell expansion are unknown. 
We hypothesized that the aged macrophage phenotype may drive the TH17 expansion more so 
than a young macrophage through the dysregulated expression of pro-inflammatory cytokines.  
To test this hypothesis, gingiva from old and young mice was dissected and processed for qRT-
PCR.  Expression of IL-6 and IL-23 was significantly increased in the gingiva of old mice compared 
to young (Fig. 5.5).  Further, periodontal disease was induced in old mice, and half the groups 
were given PLX3397, a compound that depleted macrophages.  Depletion of macrophages during 
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periodontal disease resulted in significant decreases in IL-6 and IL-23 expression within the 
gingiva during periodontal disease (Fig. 5.5). 
5.4 Discussion 
The results presented in this chapter demonstrate that inflammatory dysregulation in 
macrophages may be derived from dysregulated expression of TREM2.  The aged macrophage 
phenotype was further shown to have the potential to promote the expansion of Th17 cells in the 
pathogenesis of periodontal disease.  These results are of interest as they provide a mechanism, 
TREM2 dysregulation, for inflammatory dysregulation seen in macrophages from old mice, which 
may be a target for future translational therapeutic approaches. In addition, the relationship of the 
aged macrophage phenotype to Th17 cells, a potent promoter of periodontal disease, suggests 
a stronger link between the aged macrophage phenotype and the pathogenesis of periodontal 
disease.   
TREM2 has recently become of interest to investigators studying macrophage regulation of 
inflammation, specifically within the central nervous system (12). Much of the focus has been 
placed on TREM2 dysregulation associated with neurodegenerative diseases including dementia 
and Alzheimer’s disease (12).  The focus of TREM2 in the central nervous system was initiated 
after understanding the polymorphism to TREM2 that was involved in PLOSL and the associated 
early onset dementia (5).  Since then, recent work has demonstrated the importance of TREM2 
in regulating inflammation within the central nervous system, specially its role in proper 
phagocytosis and clearance of cellular debris (13,14).  Additional polymorphisms of TREM2 have 
since been strongly associated with Alzheimer’s disease and autism (15,21).  As stated 
previously, PLOSL additionally present with cystic bone lesions and osteoporotic features, 
suggesting TREM2 may also be involved in the regulation of inflammation within bone.  However, 
there is a lack of research investigating the role of TREM2 in inflammatory regulation within the 
skeletal system.   
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Our work has demonstrated that Trem2-/- mice have poorer healing outcomes compared to their 
age-matched controls with significantly smaller callus and less bone at day 10 post fracture. At 
later time points of healing, histological analysis demonstrated an absence of cartilage within the 
callus of Trem2-/- mice (data not shown), suggesting the fracture healed to completion.  This data 
suggests TREM2-/-  mice are still capable of healing but demonstrate a delayed healing response. 
We have also shown delayed fracture healing in old animals compared to young in Chapter 3, 
which was associated with decreased TREM2 expression in macrophages from old mice.  The 
delayed fracture healing in old mice, and the associated decreased TREM2 expression suggest 
TREM2 is important for proper fracture healing.   
Our work demonstrated an increased expression of TREM2 on macrophages at 3 days post 
fracture. However, the expression levels of TREM2 remained low, at less than 5% of all 
macrophages isolated.  While targeting the activation of the TREM2 receptor could be of 
therapeutic interest, it is also important to understand how the expression of TREM2 at the surface 
of macrophages is controlled.  Studies have shown that the administration of LPS into 
macrophage cell cultures resulted in a significant decrease in TREM2 expression, suggesting 
during periods of infection the anti-inflammatory effects of TREM2 are down regulated (3).  In 
other studies, TREM2 was over expressed on macrophages which resulted in decreased 
inflammatory cytokine expression (16).  Further work on TREM2 expression regulation during 
fracture healing may look at multiple time points throughout the healing phase to understand when 
TREM2 expression is highest and what cytokine expression may be associated with its regulation.     
Mechanisms regulating the phenotypic presentation of macrophages along the pro-inflammatory 
(M1) and anti-inflammatory (M2) spectrum and are unknown and are likely multifactorial 
considering the complex signaling involved in inflammatory regulation. However, TREM2 may 
serve as a promising target to regulate the macrophage phenotype, as activation of TREM2 
results in anti-inflammatory activity by the macrophage similar to a M2 phenotype. The presence 
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of M1 and M2 type macrophages has been shown to be related to increased and decreased 
severity of periodontal disease respectively (17). Thus, promotion of an M2-like polarization state 
in macrophages may demonstrate a therapeutic benefit (18). Delivery if IL-10 was shown to 
downregulate the M1 phenotype and was associated with decreased severity of muscular 
dystrophy (19).  In addition, promotion of M2 macrophages via delivery of IL4/IL-13 resulted in 
improved fracture healing (20).  Targeting TREM2 activation has demonstrated heterogenous 
outcomes. Reported ligands for TREM2 include mammalian cells such as macrophages and other 
immune cells, phospholipids, and whole bacteria or bacterial components; however, there is no 
consensus on a natural ligand for TREM2 (1).  Activation of TREM2 has resulted in general down 
regulation of inflammatory cytokine expression or increase in phagocytic activity depending on 
the stimulus (1). However, more work is needed to understand how TREM2 activation may control 
macrophage phenotype or directly impact wound healing.   
Finally, we wanted to understand how the aged macrophage phenotype interacted with other 
inflammatory cells.  While there are likely many effects of the increased pro-inflammatory cytokine 
expression by aged macrophages, we chose to focus on Th17 cells due to its pathogenic role in 
periodontal disease (7). This work showed that the known cytokines that drive pathogenic Th17 
cell expansion (IL-6, IL-23) are significantly increased within the gingiva of old mice compared to 
young. Expansion of Th17 cells is also increased in old mice compared to young (9). Further, 
depleting macrophages during periodontal disease induction resulted in significantly decreased 
IL-6 and IL-23 expression.  During periodontal disease we only examined the cytokine expression 
within the gingival tissue; however, isolated macrophages from the fracture callus of old mice also 
demonstrated increased expression of IL-6 and IL-23 compared to young (Chapter 3, Fig. 3).  This 
data suggests an interaction of the aged macrophage phenotype and Th17 cells that contribute 
to the increased prevalence of periodontal disease in elderly populations. 
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5.5 Conclusion 
Work in the previous chapters have shown that macrophages from old mice present an aged-
macrophage phenotype with increased pro-inflammatory and M1 gene expression. By eliminating 
the influence of the aged macrophage phenotype via macrophage depletion, periodontal disease 
severity was significantly reduced and fracture healing was significantly improved.  Further, we 
tried to understand intrinsic changes within the macrophage that may be responsible for the pro-
inflammatory characteristics of the aged macrophage phenotype. To this effort, we have shown 
that TREM2 expression is decreased with age which drove increased inflammatory cytokine 
expression and poorer fracture healing outcomes. Finally, we have shown a mechanism in which 
the aged macrophage phenotype can further promote inflammatory dysregulation and disease 
severity by driving Th17 cell expansion in periodontal disease.  Taken together, the aged-related 
changes that occur to the macrophage are likely involved in numerous disease pathologies, 
including periodontal disease and fracture healing complications (Fig. 5.6), and this work presents 
potential therapeutic targets to address the macrophage-driven inflammatory dysregulation in the 
elderly population.   
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Figures Chapter 5 
 
 
Figure 5.1: Schematic of the triggering receptor expressed on myeloid cells 2 (TREM2) signaling 
pathway. Activation of TREM2 results in activation of immunoregulatory functions of macrophages 
to downregulate inflammation. Signaling through TREM2 requires the intramembranous co-
receptor DNAX activation protein of 12kDa (DAP12). 
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Figure 5.2: TREM2 expression on macrophages increases during fracture repair.  Bone marrow 
stromal cells were isolated from the intact femur or from within the fracture callus.  Macrophages 
were isolated via flowcytometry as CD11b+, F4/80+, and additionally analyzed for TREM2+ 
expression.  TREM2 expression is low on macrophages from non-fractured bone marrow in young 
and old mice (Top Panels). Increased TREM2 expression is demonstrated on macrophages 
isolated from the fracture callus at Day 3 post fracture in young and old mice (Bottom Panels).  
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Figure 5.3: TREM2 expression is downregulated in old mice. Macrophages were isolated from 
the callus of old and young mice 3 days post fracture and analyzed via RNA-seq for the expression 
of the genes involved in the TREM2 signaling cascade (A).  Gingiva was isolated form young, and 
old mice after disease induction and analyzed for expression of TREM2 via qRT-PCR (B). Gingiva 
in TREM2-/- mice demonstrated increased inflammatory cytokine expression compared to age 
matched wild type (WT) controls (C).  (p<0.05). 
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Figure 5.4: TREM2 deficient mice demonstrate delayed fracture healing. Tibia fractures were 
created in TREM2-/- and age matched wild type (WT) controls. The fracture callus was isolated 5 
days post fracture and analyzed via qRT-PCR for expression of inflammatory cytokine genes (A). 
Fractures were isolated 7, 10, and 14 days post fracture and histological slides were prepared 
and stained with HBQ (B).  Slides were analyzed via stereology for quantification of callus, bone, 
and cartilage volume (C). (p<0.05). 
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Figure 5.5: IL-6 and IL-23 expression is increased in the gingiva of old mice and can be reduced 
by macrophage depletion. Gingiva was isolated from healthy old and young mice and analyzed 
via qRT-PCR for relative expression of IL-6 (A) and IL-23 (B). Periodontal disease was induced 
in old mice and half the mice were given PLX3397 to deplete macrophages throughout the 
induction period. After 7 days of disease induction the gingiva was and analyzed via qRT-PCR 
for relative expression of IL-6 (C) and IL-23 (BD. (p<0.05). 
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Figure 5.6: Graphical summary of findings.  Infiltrating macrophages at the site of inflammation 
are transcriptionally distinct in old mice compared to young.  Infiltrating macrophages from old 
mice demonstrate increased M1 markers and pro-inflammatory gene expression compared to 
young.  TREM2 expression was decreased in macrophages from old mice which is hypothesized 
to be a driver of the inflammatory dysregulation in old macrophages.  Old mice demonstrated 
increased periodontal disease severity and delayed fracture healing. Disease severity and 
fracture healing were improved with the depletion of macrophages in old mice.   
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